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Abstract 
 
Nanomaterials entered the biomedicine already at the beginning of the 
millennium and they still bring new and unique advances and possibilities for 
treatment, diagnosis and regeneration, thus they continue to facilitate the 
development of personalized medicine. Interactions at nanoscale allow until then 
unconceivable opportunities to influence processes on molecular level. The 
completely new perspectives of nanomaterial applications jointly raise attention 
concerning health and environmental safety issues. Although a lot of novel 
biomedical applications of nanomaterials have emerged, the vast majority is still 
found to be at the stage of a concept. The consistent basic in vitro research of 
elemental interactions of nanomaterial with biological environment should represent 
an essential part of its development.  
The concern of this thesis was to describe the cytocompatibility and 
interactions of two types of nanomaterials with different human cells. First, ultra-fine 
grain titanium was tested for prospective use in implant development. We confirmed 
its positive effect mainly on the growth of osteoblasts and recommended the further 
pre-clinical trials of this material in a form of a bone or dental implant. Second, 
several types of ultra-small (˂ 5 nm) nanoparticles of different origin (silicon, gold 
and platinum) were described in various conditions to obtain information about their 
time- and concentration-dependent cytotoxic potential and behavior in cell culture. 
The formation of protein layer on nanoparticle surface, which naturally occurs in 
biological fluids, proved to be a crucial parameter for interactions with various cell 
types. For subsequent research, a series of modifications of mentioned nanoparticles 
were proposed in order to improve their performance in living organism. 
This thesis elucidates the importance of basic in vitro evaluation of 
nanomaterials and emphasizes the need of interdisciplinary cooperation in this 
complex topic of integration nanotechnology into biomedicine. 
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1 Novel Approaches in Regenerative Medicine 
 
Increasing average age of the population places demands on a longtime 
maintaining of the quality of life. Tissues of a human body are no longer capable of 
sustaining of their proper functions due to age, chronic disease, damage or simply 
limited regenerative capacity of certain organs (Baddour et al., 2012). Regenerating 
the damaged tissues, which have not the possibility to recover by themselves, is the 
main concern of regenerative medicine. This biomedical approach promotes the rapid 
development of the novel therapies, which offers a complex recovery without 
undesired side-effects while avoiding the exacting organ transplantation or a lifelong 
treatment by medications. General restoration of a structure and function of the 
damaged tissues and organs is the crucial description differing regeneration from 
reparation where the   restitution is based on epithelial proliferation and fibrosis 
which mostly cause the unpleasant scaring (Mason and Dunnill, 2007). Original 
concept of regenerative medicine still changes through the time as it accommodates 
to the interdisciplinary linkage and to the novel discoveries in the field of therapeutic 
techniques.  
Nowadays, due to the fast progress in medical technologies regenerative 
medicine also encompass tissue engineering, early recognition of the development of 
the disease by the wide range of diagnostic systems, targeted drug delivery systems 
and microelectronic devices (Eberli, 2014; Williams, 2009). Treating complex 
diseases by promoting the self-healing processes in organism cannot be considered as 
a straightforward therapy but it calls for the interplay of synthetic materials, cells and 
a cascade of factors affecting their mutual interactions (Qi et al., 2015). The same 
criteria must be met also for diagnostic or targeted delivery techniques where the 
outcomes of therapy are highly dependent on the reactions of the inner environment 
of the body and the material used. 
Employing the aspects of cell biology, material science and biomedical 
engineering into one therapeutic discipline enables a whole new look into the 





2.1 Definition and Types 
Biomaterials are one of the essential cornerstones of human tissue resurgence as 
they can replace or repair damaged tissue structures. First attempts of definition of 
the term „biomaterial― were completed on Consensus Conference on Definitions in 
Biomaterials Science by the European Society for Biomaterials in 1987 (Williams, 
1987) and later were modified to its preferred definition in 1999 as „a material 
intended to interface with biological systems to evaluate, treat, augment or replace 
any tissue, organ or function of the body― (Williams, 1999). According to IUPAC 
definition from 2012 biomaterial is described as ―a material exploited in contact with 
living tissues, organisms, or microorganisms‖ (Vert et al., 2012) but here we must 
point out that the main scope of biomaterials is focused on health care (Williams, 
2009). 
Technological advancements still change the original definitions and 
expectations determined for biomaterials more than 50 years ago.  The former idea of 
inert substance with mostly passive functions has been replaced by the design of 
materials with bio-inductive properties (Keane and Badylak, 2014). Recent approach 
tries to involve biomaterials in active regeneration to help the renewal of the 
nonfunctional tissue by supporting the healing process of the organism. 
According to the material science, biomaterials encompass substances based on 
metal, ceramics and polymer or they form a composite of different materials 
(synthetic or nature-derived). Moreover, some of the materials listed under the 
groups mentioned above can be categorized as biodegradable in the classification 
(Ferraro, 2016). The strict sorting concept according to the type of material has 
become very confusing as the techniques of nanotechnology and self-assembly 
enabled fabrication of the brand new complex structures purposefully developed for 
utilization in health care (Williams, 2009).  
 Evolution of biomaterials started with substances those mechanical properties 
matched to the structure of the damaged tissue without invoking undesirable 
reactions of the body. Such conditions were met by the first pure metals or alloys e.g. 
18-8 stainless steel in 1920 (Fazel, 2011) or by polyester fiber Dacron® in 1953 
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(Batty et al., 2015; Keane and Badylak, 2014). Further research led to the 
development of improved materials with value added for superior tissue integration 
(hydroxyapatite coating), degradability (collagen) or anti-inflammatory activity 
(antiseptic or antibiotic coating). Currently, only materials with the enhanced 
bioactivity find their way to the clinical use and can be either artificially synthesized 
or based on natural materials. Improving the bioactive properties of synthetic 
materials can be achieved by a) coupling with the proteins naturally occurring in 
extracellular matrix (ECM), e.g. growth factors or adhesive proteins (He et al., 2008; 
Zhu et al., 2009) or b) changing physical and mechanical properties of the material 
by surface treatment (micro- and nanofabrication) or c) by size and shape adjustment 
of particles (Broz et al., 2009; Chen et al., 2014; Toy et al., 2014). Natural materials 
mostly focus on the most authentic imitation of the ECM by forming so called ECM 
scaffolds based predominantly on nature-derived polymers (Badylak et al., 2011; 
Valentin et al., 2010). 
 
2.2 Biomaterials in Regenerative Medicine 
Broad spectrum of biomaterials serves as universal tool in many applications in 
human medicine. Indeed it should be mentioned that for certain biomaterial there is 
an application specificity therefore the success in some type of application cannot be 
automatically expected in different one (Keane and Badylak, 2014).  
History of biomaterials in regenerative medicine is dated back to the first 
aseptic surgery techniques which facilitated the fixation of long bone fractures by the 
use of metallic screws and implants. First joint replacements by metal alloys 
followed in rapid succession (Parida et al., 2012). Implantable bone plates, joints and 
dental devices still make up the majority of biomaterials used in tissue replacement. 
Another extension of application potential is recorded with the synthetic polymers 
and their utilization as corneal, blood vessel and heart valve replacements. In general, 
implantable devices represent the highly diverse group of material types of different 
origin (artificial, nature-derived), structure (composites of more materials), shapes 
(fibers, sheets, films, etc.) and forms (solid, foam, soft fillings, etc.).  
A completely new direction in regenerative medicine has been created due to 
the connection to recent findings in the field of physics and chemistry. From this 
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point on, optical (Parak et al., 2003) or magnetic (Pankhurst et al., 2009) properties 
of the new materials have led the way to the novel imaging and real-time sensing 
techniques (Liu et al., 2015; Mattoussi et al., 2012; Nichols et al., 2013). Knowledge 
of the physicochemical properties of certain materials also enabled introduction of 
the incoming therapeutic methods based on cell-specific targeting e.g. cancer-
cytotoxic probes (Kotler et al., 2013; Lin et al., 2015), drug delivery systems (Wang 
et al., 2015, 2014) or gene therapy (Kim et al., 2015).  
Nowadays, biomaterials in regenerative medicine can be sorted either by the 
way of their use or by their site-specificity (organ, body system) (Parida et al., 2012). 
Systemic summary of various biomedical applications of biomaterials is listed in 
Table 1. The most important aspects common for all biomaterials with the intention 
of clinical use include biocompatibility, systematical inert properties (non-
inflammatory, non-allergic, non-carcinogenic) and possible manufacturability and 
reasonable financial demands. 
 
 
 Table 1 – Different approaches of biomaterial utilization in biomedicine 
 
2.3 Biocompatibility and In Vitro Evaluation 
The essential principle of biomaterials to distinguish them from any other 
material is the fact that they can co-exist with the human body tissues while keeping 
their inert properties assuring harmless effect towards the recipient. This statement 
gave the foundation to the subject of biocompatibility. Biological and chemical 
inactivity has always been of capital importance since the introduction of the first 
generation of the long-term implantable medical devices more than 60 years ago. 
Biocompatibility in this early biomaterial research was defined as a summary of 
situations, which must not occur after the contact of the biomaterial with the human 
tissue. The primary parameters for selection of the materials were based on the local 
Biomedical utilization Example
tissue replacement joint prostheses, vascular grafts, artificial heart valve
defect correction bone plates and screws, contact lens, mammoplasty
drug delivery targeted drug release, gene therapy
diagnosis imaging techniques, biosensors
ex vivo research gene transfer via non-viral vectors
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or systemic non-toxicity, non-immunogenicity, non-thrombogenicity, non-
carcinogenicity and many other harmless principles (Williams, 2008).  
In general, biocompatibility should not be considered as a simple attribute of 
certain material but more likely as the whole concept of abilities to perform its 
desired functions. Therefore we have to keep in mind that biocompatibility should 
not be solely reliant on the intrinsic characteristics of the material but depends on the 
site and situation of intended use (Naahidi et al., 2013). Anatomical location is of a 
crucial importance when evaluating biocompatibility as the reactions to the presence 
of biomaterial can significantly vary in dependence to the certain tissue. Therefore 
we cannot predict if the required or undesired adverse effect will occur when the site-
specificity of the biomaterial is not respected (Nicolete et al. 2011; Anderson et al. 
2008). Moreover, as it was mentioned before, biomaterials are used in still more 
complex situation including drug delivery, osteoinduction of implantable devices or 
real-time biosensoring, where the inactivity of the material is definitely out of their 
intention. Hence, the redefined paradigm of biocompatibility as a beneficial ability 
for medical therapy was proposed by D. F. Williams in 2008 (Williams, 2008).  
Immense variability of tissue responses to the different biomaterials creates 
very challenging field for the standardization of the processes for testing of 
biocompatibility. Development of such standards must be dynamic and continuous 
because of the rapid progress in technologies (Hanks et al., 1996). Many challenges 
emerge when we become conscious of the fact, that biocompatibility influence a 
variety of external issues e.g. the final design of the device (Pizzoferrato et al., 1994; 
Polikov et al., 2005) and the patient-to-patient variability. Risk assessment therefore 
requires performing the biocompatibility studies on each new material in the most 
detailed way. In addition, since the amount of new materials increases quickly every 
year there is a need of a simple, fast and consistent initial in vitro screening to 
evaluate whether the material is suitable for more complex testing. Above that, 
outputs of such in vitro models should be in good correlation to the very 
comprehensive in vivo situation.  
Significant efforts have been focused on this difficult task and so many 
guidelines have been produced until the standard guideline document ISO 10933-1 
was first issued (International Organization for Standardization, 2009). Initial stage 
of biocompatibility evaluation in vitro is called cytotoxicity tests and they consist 
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merely from morphological observations, viability test, or adhesion assessment. 
Second stage focuses on the functional evaluation such as inhibition of the 
proliferation, inhibition of metabolic activity or phagocytosis index. In this phase 
mostly continuous cells lines are chosen because of their uniform characteristics and 
fast growth which allow to perform large number of tests in a short period of time. 
Further evaluations include immunomodulation activity, bone-forming activity or 
modulation of coagulation for which the primary cells such as macrophages or 
osteoblasts are a more suitable choice (Pizzoferrato et al., 1994).  
Extreme sensitivity of in vitro testing assures the recognition of even very low 
toxicity potential of the material as this conditions lack the possibility of elimination 
of the waste products. The overestimation of the cytotoxicity together with the 
limited time for estimations are the major drawbacks of the in vitro biocompatibility 
evaluation. On the other hand, in vitro tests are a valuable tool for investigation of 
specific interactions even at the molecular level and clarification of the changes in 
cell functions. Accompanied with the results from histological or blood analysis, cell 
culture in vitro evaluations open up the way for the biomaterial to advanced pre-







3 Nanomaterials  
 
3.1 Definition and History of Nanomaterials 
The prefix ―nano-‖ itself labels and refers to very small-sized object as it 
originates from the Greek word meaning ―dwarf‖. In the modern era, signifying 
certain subject, activity or industry with the ―nano‖ label becomes increasingly 
popular within the scientific world although many of these designations are not even 
precisely defined (Buzea et al., 2007). In metric system, nanometer represents the 10
-
9
 m and the dimensions of the objects in this range of length are termed as 
nanoscaled. The size reliance is fundamental for all the definitions of nanomaterial 
created so far though the exact size range is inconsistent among them.  
International and many national regulatory organs have proposed numerous 
nanomaterial definitions and terminologies with the core aspects concerning external 
dimensions, solubility, new properties, aggregation or distributional thresholds 
(Boverhof et al., 2015). Nowadays, only definitions of the normative character on 
European or global level should be accepted to avoid conflicted descriptions. In 2011 
European Commission published Recommendations on the definition of 
nanomaterial as follows: ―Nanomaterial is natural, incidental or manufactured 
material containing particles, in an unbound state or as an aggregate or as an 
agglomerate and where, for 50 % or more of the particles in the number size 
distribution, one or more external dimensions is in the size range 1 nm - 100 nm. In 
specific cases and where warranted by concerns for the environment, health, safety 
or competitiveness the number size distribution threshold of 50 % may be replaced 
by a threshold between 1 and 50 %.‖ (EU Commission, 2011). Alongside, the 
Recommendations advert to the ISO document of terminology and definitions of 
nano-objects which was revised in 2015 as ISO TS 80004-2 (International 
Organization for Standardization, 2015). According to ISO definitions, nanomaterial 
is described as a material with at least one external nanoscaled dimension or 
exhibiting internal structure in the nanoscale. The term ―nanoscale‖ in here denotes 
the length interval approximately from 1 nm to 100 nm. In accordance with the 
number of nanoscaled external dimensions ISO characterizes the different shapes 





Figure 1 – Illustrational scheme of various shapes of nano-objects. Adopted from 
ISO TS 80004-2 (International Organization for Standardization, 2015). 
 
Naturally occurring nanomaterials have always been an integral part of our 
environment both in the inorganic and organic systems. Hence, many of them could 
only been discovered thanks to recent advances in technology, which help us to 
localize, isolate and describe the vast range of their structural and chemical varieties. 
As a common natural substance, nanomaterials can be found in volcanic ash, sand, 
dust or in biological matter (Lohse, 2013). Some prominent representatives have 
already been used for research purposes and their structure have been studied and 
emulated in order to create a template for synthetic nanomaterials with desired 
properties for diverse functions, e.g. lotus leave inspired the development of 
hydrophobic fabrics and coatings (Feng et al., 2002). As well as the natural ones, 
also so called incidental synthetic nanomaterials are present in our environment in a 
large extent as they are the secondary product of human activity (combustion 
engines, mining). 
Numerous man-crafted nanomaterials can be traced back to the ancient times 
with the first understanding and manipulation of the material (colloidal gold and 
silver in glass). With the sophisticated instrumentation of the modern era starts the 
actual development of nanotechnology. Although the ideas of nanoscale 
manipulations were proposed before, the inception of the concept of the engineering 
on the atomic scale is linked to Richard P. Feynman and his ground-breaking speech 
on the meeting of the American Physical Society in 1959 called ―There‘s Plenty of 
Room at the Bottom‖ (Feynman, 1960). In 1974, the term nanotechnology was 
coined for the first time by Norio Tamiguchi and this field of intentionally machined 
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nanomaterials started to develop extremely fast. Following decades have brought a 
number of significant discoveries - Buckminsterfullerene ―buckyball‖ (C60) in 1985 
awarded by Nobel Prize in Chemistry, semiconductor quantum dots in 1985, carbon 
nanotubes in 1991 and scanning force microscope as an unique tool for quantitative 
and qualitative description of nanomaterials. In the early 2000‘s the rapid increase in 
nanomaterial engagement in consumer products fabrication was recorded (sun-
screens, batteries, digital cameras). 
Nanomaterials owe their unique properties to two factors which radically 
change their behavior in contrast to the original chemically identical bulk material: a) 
quantum confinement – phenomena of delocalized electron states causing 
discontinuous quantum effects  and b) surface effects – smoothly scalable effects 
related to the fraction of atoms at the surface (Roduner, 2006). Both of these aspects 
influence the nanomaterial final mechanical, optical, electrical, and magnetic 
properties as well as chemical reactivity (Buzea et al., 2007). Nowadays, two main 
strategies are used for fabrication of almost every nanomaterial. First called bottom-
up technique provides de novo synthesis of products as the nanoscale versions of the 
bulk material. Typical outcome structures of this approach are quantum dots or 
carbon nanotubes. The other technique works the other way around, thus it makes 
use of already existing materials and modifies them to reach the nanostructure. This 
strategy is called by the term of top-down technique and enables the fabrication of 
various nanopatterned substrates (Verma et al., 2011). It could be stated, that all 
current microelectronics is fabricated using this approach. 
 
3.2 Pros and Cons of Nanomaterials in Biomedicine 
Biological systems and their building materials very often feature hierarchical 
structure and thereby form natural functional nanomaterials as it was mentioned in 
chapter 3.1. Hierarchical structures of many biological materials have been studied 
from the smallest nanoscale to the macroscale, moreover, the arrangement of the 
particular features in building blocks of organisms has been submitted to the detailed 
examination to connect structure to its mechanical, biological and chemical 
properties (Bechtle et al., 2010). The longest investigations have been performed on 
the structure of a bone (Reznikov et al., 2014; Rho et al., 1998). Bone is a part of the 
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family of mineralized connective tissue which is distinguished by a complex seven-
level hierarchical structure of different organic and inorganic components (Fig. 2) 
working in a concert to provide its unique supportive, protective and storage 
functions. 
 
Figure 2 – Hierarchical organization of the bone structure. Adopted from (Rho et al., 
1998). 
 
Nanomaterials can mimic surface as well as inner properties of such natural 
tissues. Many bottom-up and top-down fabrication techniques are currently available 
to produce ―smart‖ complex nanomaterials which can not only imitate the natural 
tissue environment but also influence the cellular responses at the molecular level 
(Engel et al., 2008). Nanometer dimensions enable the direct interaction of cells and 
their surroundings so the tunable physicochemical and biomimetic properties of 
nanomaterials help to overcome the limitations associated with the actual 
regeneration strategies (Zhang and Webster, 2009). Integration of nanotechnology 
and medicine (sometimes inaccurately denoted as nanomedicine) opens up new 
possibilities for controlling the biochemical and mechanical microenvironment of the 
human body tissues. The appropriate design of selected nanomaterial can further 
facilitate the cell growth and modification and also deliver agents and track specific 
regions or cells within the body (Verma et al., 2011). 
The unusual properties of nanomaterials indeed raise awareness about their 
possible unrecognized negative or even toxic effect for the biological systems and 
the environment. Incidental and many commercial nanomaterials (cosmetics, 
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sporting goods, waterproof clothing) surround us in everyday life for many decades 
and their global expansion caused the birth of a new type of toxicology discipline – 
nanotoxicology. Involvement of nanomaterials in biomedicine raises concerns 
especially because of their affection of cellular and subcellular processes, 
uncontrolled deposition in the body or undesired penetration through the biological 
membranes due to the formation of complexes with proteins (Nel et al., 2006). The 
unexpected effects can be avoided by a proper compliance of series of the 
nanotoxicology requirements: a) sufficient characterization of nanomaterial, b) 
respecting of the good scientific practice and standard operation protocols, c) use of 
appropriate controls and reference materials (Krug, 2014). Still, of course, it cannot 
be guaranteed whether any adverse effect occurs from a long-term point of view, 
thus, researchers must be motivated to first of all pursue and publish also the 
negative studies equally as the ―positive‖ ones.  
 
3.3 Nanosurfaces 
3.3.1 Important Aspects for Application in Biomedicine 
From the perspective of nanomaterial classification, nanosurfaces (NS) can be 
described either as one-dimensional since they exhibit nanoscale structure only in 
one dimension or as two-dimensional (2D) when considering their plate-like shape. 
The term of NS can be further specified or subdivided to nanolayers, nanofilms or 
nanocoatings. The confinement to the nanoscale may be produced by artificial or 
self-assembly deposition on a substrate (bottom-up) or the surface of the original 
sample may be mechanically or chemically degraded (top-down). It follows that the 
actual nanostructure may be of a different origin than the base substrate therefore it 
serves as a coating to provide the unique nano-related properties to the selected bulk 
material. The latter approach keeps the characteristics of the bulk material (stiffness, 
chemical composition) while amending only the surface topography.  
Nanomaterials in the form of a sheet, a film or a coating have an unambiguous 
purpose in biomedicine and that is the nano-assisted in-situ tissue regeneration (e.g. 
chronic wound healing). The influence of devices with nanostructured surface is 
immense as they enhance a vast array of processes necessary for a proper healing in a 
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cell-material contact site, moreover, they can attract endogenous stem cells to the 
affected area (Qi et al., 2015). Directing cellular processes like extracellular matrix 
deposition, attachment/adhesion of required cell type with subsequent fast 
proliferation and differentiation into designated lineage is enabled by creation of the 
convenient nano/microenvironment (Lutolf et al., 2009). The resulting biological 
performance of the surface is dependent on several properties – roughness/porosity, 
chemistry, wettability, stiffness, charge and surface energy and usually affecting one 
variable causes alteration of the others (Gittens et al., 2011; Kalbacova et al., 2009). 
In general, surface roughness and chemistry are considered as independent 
parameters, though in practice it is complicated to prove it. Cell responses to the 
biocompatible nanomaterials of different combination of surface characteristics 
maintain the logical sequence of the contact-adhesion-spreading-proliferation events 
however unfavorable substrates exhibit low efficiency and prolonged periods of 
induction of subsequent processes (Liu et al., 2007). General rule for designing NS is 
to keep the high degree of hydrophilicity and surface energy and to adjust the 
stiffness of the material to the requirements of the type of adherent cells (Rehfeldt et 
al., 2007; Rupp et al., 2006).  
Above all, roughness of the surface and specifically the nano- and microscale 
topography represent the crucial feature for interaction of cell cytoskeleton with 
material, thus profoundly influence the cell and tissue behavior through mimicking 
the extra-cellular matrices. The unique architecture of topography increases protein 
adsorption and bioactivity prior to the actual cell adhesion. Promotion of protein 
(fibronectin, vitronectin, laminin) attachment occurs due to significantly increased 
surface area of nano-topography and such thoroughly assembled protein basis 






Figure 3 – Comparison of nanosurface to conventional materials in the promotion of 
cell responses. Adapted from (Zhang and Webster, 2009). 
 
The impact of topography is more pronounced when certain strategies of 
patterning are employed. Cells detect and respond to the topographical features based 
on their size and organization on the surface. Micro-sized dimensions correspond to 
the size of the whole cell thus the recognition is driven by the whole-cell guidance 
(Dalby et al., 2014). Such phenomena rather suppress cell proliferation though it is 
effective in promoting the differentiation of cells (Saito et al., 2010; Schwartz et al., 
2009). On the other hand nano-sized dimensions may have a major impact on 
cellular responses as their dimensions correlate to the cell-surface receptors (Dalby et 
al., 2014). Moreover, disordered arrangement of the features of the same size has 
positive influence on cell differentiation compared to the ordered patterns (Dalby et 
al., 2007).  
3.3.2 Bio-implants with Nanosurface 
The surface treatment to nanoscale provides additional functionality to 
biomaterials and enables their tailoring to the needs of implantable devices. 
Nanostructured implants make use on the places of contact with the damaged tissue 
where they can play a key role in stimulating regeneration. Conventional implants, 
anyhow made from cytocompatible materials, still lack the long-lasting lifespan 
inside the tissues and gradual rejection occurs eventually in majority of the cases in 
the range of 10 – 15 years (Zhang and Webster, 2009). 
Utilization of nanostructured implants takes place both in hard and soft tissue 
regeneration accordingly to the mechanical characteristics of the material. Synthetic 
and natural biodegradable polymers or carbon nanotubes prevail in the implantology 
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of soft tissues. Nowadays, the greatest emphasis in soft tissue engineering besides 
biocompatibility is placed on the right timing of biodegradation to guarantee enough 
time for sufficient attachment, spreading (eventually orientation) and growth of the 
right cell type on the affected area and to start degradation at the very end of the new 
tissue formation. The significant achievements are made mainly in vascular and skin 
regeneration where especially biodegradable polymers (e.g. PLGA, PLLA, PCL) are 
used in a form of composite nanofibers (Hasirci et al., 2006). Promises are also made 
for neural and lately for bladder tissue regeneration. In these cases, we talk about the 
implants as scaffolds since most of them act as the whole 3D frame nanostructure to 
let the tissue grow throughout the whole implant and their surface characteristics are 
not emphasized. 
On the other hand, the hard tissue (bone, teeth, cartilage) regeneration often 
requires not only promotion of the healing processes but also sufficient mechanical 
resistance to keep the supportive competence of the tissue. In bone tissue 
regeneration the three ways of implant integration are described: osteoconductivity 
(mechanical support), osteogenicity (cell attraction) and osteoinductivity (cell 
differentiation) (Hasirci et al., 2006). Crucial for bone remodeling is the cooperation 
of bone-forming (osteoblasts) and bone resorbing (osteoclasts) cells. Osteoclasts 
prepare the surface of the previously-formed bone by the resorption of small cracks 
leaving the upper structure formed into numerous micro- and nanofeatures which are 
subsequently recognized by osteoblasts (Mulari et al., 2004). Many studies 
confirmed that the micro-scale pits and irregular nano-scale roughness on the surface 
of the implant represent the most suitable osteogenic and osteoinductive material 
(Chen et al., 2012; Gittens et al., 2011; Ostrovska et al., 2015). Integration of the 
implant to the bone tissue is a fundamental prerequisite to prevent loosening in load-
bearing conditions. Various nanophase metals and ceramics have been designed up 
to date as bone implants, often with the use of hydroxyapatite as a coating because of 
its high similarity to the mineral component of the bone (Kokubo et al., 2003). 
Polymer and composite scaffolds as alternatives to metals are also on the rise in hard 
tissue regeneration; however, their use is limited to the non-load-bearing applications 
now. For now, the same situation is with cartilage and dental implant, where the 
nanostructured mechanically resistant implants are still more preferred (Burns et al., 
2009; Guida et al., 2013).  
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3.3.3 Cells Interactions with Nanosurfaces 
In standard situations, cells are not in direct contact with the artificial substrate. 
Contact is mediated by their interaction with protein layer which adheres to the 
surface of the material in the first place. Origin of this protein layer is in the standard 
supplemented cultivation media or in the body fluid for in vitro and in vivo 
conditions, respectively (Dhowre et al., 2015; Mager et al., 2011). The dynamics and 
highly complex structure of natural cellular environment still represents considerable 
challenge for translation into biomaterial and healthcare research. 
In order to make up the highly organized tissue, adhesion-dependent (adherent) 
cells need to be anchored to their environment and they need to communicate and 
cooperate with each other. All the mentioned processes are possible thanks to the 
matter in the inter-cellular space which is denoted as extracellular matrix (ECM). 
Formation of ECM was crucial for the evolution of multicellular organisms and in 
most of the tissues ECM represents the vast majority of their total volume. ECM can 
be described as heterogeneous protein-based matrix which involves supportive, 
binding and freely mobile structures. Cells manage to form ECM via secretion of 
molecules of different abilities - structural support, elasticity, cell behavior 
regulation, tensile forces resistance etc. Furthermore, cells actively remodel ECM by 
the secretion of proteolytic enzymes (e.g. cathepsins, metalloproteinases) and they 
also release soluble factors controlling local and distant environment (Dhowre et al., 
2015). 
The main constituents of ECM are fiber proteins collagens which work as a 
skeleton for structural support of the matrix and enable binding of other proteins 
(Kim et al., 2011). In a bone tissue, collagens (type I and type V) make up 90% of 
the whole ECM. Next, elasticity of ECM is provided by protein elastin and the actual 
contact with cell membrane proteins is mediated by proteins like fibronectin, 
vitronectin and laminin, which present various peptidic motifs serving as ligands for 
binding of cell membrane receptors called integrins. 
As it was mentioned at the beginning of this chapter 3.3.3, the very first contact 
of artificial substrate with biological environment initiates coating of the surface with 
proteins. Qualitative and quantitative assembly of this layer is determined by the 
composition of the biological fluid, protein concentration, size and mainly by 
specific surface-protein interactions mediated by surface properties (Rabe et al., 
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2011). Many studies were conducted to improve cell-material interactions via 
preliminary adsorption or directed coating the material by specific peptides to mimic 
ECM. The most well-known example in general use is the peptidic sequence of ECM 
ligands – RGD (Arg-Gly-Asp) which was first discovered in fibronectin (Verrier et 
al., 2002; Zhu et al., 2009). 
Synchronization of cells and their close surrounding on the interface is essential for 
cohesion of the whole tissue as it influences adhesion, spreading, proliferation, 
migration and differentiation of cells (Cai and Heilshorn, 2014). Anchoring to the 
surface by adhesion is crucial for survival and proper function of adherent cells. 
Adhesion of cells to ECM represents a few-phase event. At first, weak 
physicochemical forces (ionic, van der Waalls bonds) get involved and the early cell 
attachment is mediated by electrostatic interactions. Following biological adhesion 
starts with the transmembrane proteins integrins recognizing ECM ligands and 
formation of the first receptor-ligand pair. This specific integrin binding provides 
mechanical connection of inner cytoskeleton to ECM and enables the transmembrane 
signalization and gene expression regulation (Anselme, 2000). In latter phase the 
total adhesion strength is increased by the formation of numerous receptor-ligand 
bonds and the cytoskeleton undergo the active reorganization. Cell body flattens and 
spreads along the surface which causes the enlargement of the contact area. Adhesion 
strength amplifies as reorganization of cytoskeleton continues and more adhesion 
sites establish. Morphologic changes in cell shape and size (flattening, spreading) 
may be one of the indicators of the cell-ECM attachment (Ahmad Khalili and 





Figure 4 – Schematic model of cell-nanosurface interactions on different scales. 
Adopted from (Gittens et al., 2011). 
 
Sites of mature adhesions between cells and ECM substrate are molecular 
complexes referred to as focal adhesions (FA) or adhesion plaques and are typical for 
in vitro cell culture environment as this tight junctions (10 – 15 nm) occurs only 
rarely in vivo (endothelial cell resisting high hydrodynamic stress) (Anselme, 2000). 
The formation of FA occurs in cells with low motility and is promoted by the 
connection of ECM proteins with external part of cell membrane receptors (integrins) 
which further mediate interaction to the cytoskeleton proteins (actin) via intermediate 
proteins (talin) and more transduction proteins (vinculin, paxillin, tensin). FA thus 
translate the external mechanical and topographical information about the substrate 
to the intracellular environment and contribute to the maintenance of cell shape by 
influencing the actin cytoskeleton architecture. 
The significant influence of proteins adsorbed on nanosurface on cellular 
behavior was confirmed by many in vitro studies which evaluated cell characteristics 
in presence or absence of serum proteins in culture media (Audiffred et al., 2010; 
Kalbacova et al., 2012; Verdanova et al., 2012). The important outcome of these 
works suggests that in initial serum-free conditions cell adhesion, proliferation and 
size are affected mainly due to different attachment mechanisms including hydrogen 
or van der Waalls bonds between the bare substrate and non-integrin receptors 
(glycoproteins). In following phase, cells start to produce ECM proteins and thus the 
non-specific sites of attachment are replaced by FA and proliferation or 
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differentiation of cells may continue in the same manner as in serum-enriched 
conditions. Although it is important to emphasize that the initial phase is crucial and 
further cell-material interactions could be negatively influenced. 
Topographical features of nanosurface are of a special importance in formation 
of FA, especially in their localization, size and shape. FA formed on smooth surfaces 
are usually smaller with uniform distribution along the cell membrane whereas in the 
case of rough surface FA are preferentially localized in cell extensions (Anselme et 
al., 2000; Ostrovska et al., 2015). FA translated information of the state of external 
environment influence the cellular size and shape variability among different 
substrate topography as it was confirmed for various cell types (Chen et al., 2012; 
Teng et al., 2012), moreover, such information could lead to differences in ECM 
protein (mainly collagen) production (Kubo et al., 2009; Zhao et al., 2010). 
3.3.4 Nanostructured Titanium 
Titanium (Ti) still represents one of the most widely used metallic material for 
implants in trauma surgery and in oral and orthopedic medicine (Mishnaevsky Jr. et 
al., 2014). The mentioned medical disciplines deal with ensuring the best possible 
performance of implanted devices to lower the recurrence of operational 
interventions to the body. In this field, one significant challenge still resists and that 
is the creation of an artificial implant which would exhibit high fracture toughness 
while meet the mechanical elastic properties of the hard connective tissue. Ti exceeds 
other materials in several mechanical and biomedical characteristics. Corrosion 
resistance is provided by the passive layer of TiO2 which spontaneously creates an 
inert barrier on the surface preventing any ion release thus ensuring Ti the status of 
highly biocompatible material  (Browne and Gregson, 2000). Light weight, high 
formability and low elastic modulus enable easy fabrication of low-weight implants 
durable in the bending stress conditions (Greger et al., 2009). However, the 
mechanical strength under the long-term cyclic loading conditions has always been a 
major drawback of commercially pure Ti (cp Ti). 
Addition of alloying elements allowed the significant improvement of fatigue 
strength yet even the most widely used alloy Ti-6Al-4V deals with the problem of 
slow leach-out of metal ions and their gradual accumulation in organism (Browne 
and Gregson, 2000). The brand new approach in manufacturing of cp Ti 
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encompasses the nanostructuring concept of grain refinement (Polyakov et al., 2014; 
Valiev et al., 2006). Inner nanostructure bestow cp Ti the desirable mechanical 
strengthening qualities, while it enables further surface treatment by nanostructuring 
of a different type (mechanical grinding, sand blasting, acid etching) for facilitated 
cell attachment (Estrin et al., 2011; Ostrovska et al., 2015). The correct tissue in-
growth is the best possible fixation mechanism of the implant, so only proper 
incorporation can assure the full use of all mechanical properties of nanostructured 




3.4.1 Applications of Nanoparticles in Biomedicine 
According to dimensionality, nanoparticles (NPs) are described as 3D 
nanomaterials since they exhibit nanoscale size in all 3 dimensions. From the 
morphological point of view, we distinguish various shapes (spherical, cylindrical, 
oval or cubic) which may be uniform in the whole sample in the case of engineered 
NPs or they could represent a collection of different shapes which occurs mainly in 
natural or incidental NPs (dust, emission vapors). Dispersions of one type of 
synthetized NPs are usually bound to carrier phase which in the vast majority is 
liquid (colloid, suspension). Though NPs dispersions also exist as aerosols or they 
could be freely assembled in a powder formulation (Buzea et al., 2007). The 
importance must be attached to the agglomeration tendencies, whereas some kind of 
NPs in defined conditions can only exist in an agglomerate state, thus their behavior 
corresponds to much larger particles (Bruinink et al., 2015). When considering the 
final effect of synthetized NPs, the mostly discussed issues involve composition, 
charge, size distribution or solubility. And even more variables join, when 
biomedical application is under consideration (biodegradability, clearance, 
interactions with proteins etc.).  
A wide range of tunable NPs properties projects into numerous applications 
across biomedicine and generally can be divided into 3 categories: therapeutics, 
diagnostics and imaging (Parveen et al., 2012). All categories preferably use NPs as 
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nanoscale probes with the size similar to the proteins which allow us to target or even 
influence various processes on sub-cellular level. Specific targeting and consequently 
effective delivery of therapeutic agents have the potential to replace traditional 
medicines because of avoiding the undesirable side effects especially with anti-
cancer chemotherapeutics. Loading chemotherapeutics onto NPs and their potency 
against various cancers have been successfully demonstrated with doxorubicin, 
paclitaxel or carboplatin (Elbialy et al., 2019; Ma et al., 2019; Zhu et al., 2017). 
Some types of NPs display anti-tumour activity by themselves through 
radiosensitization, phototermal therapy or magnetic hyperthermia (Zarschler et al., 
2016). Targeting is achieved by passive or active principles using enhanced 
permeability of affected tissue or conjugation of specific ligands, respectively (Lin et 
al., 2015; Polo et al., 2017). Besides drugs, other cargos for promising future delivery 
via NPs are vaccines, antimicrobial agents or genes.   
Molecular diagnostics represents sensitive alternative to the present-day 
clinical laboratory techniques. Detection of different proteins, pathogens, cancer cells 
or low-expressed biomarkers of a disease in blood assays or tissue biopsies is usually 
based on spectroscopic evaluation of optical or magnetic quantities of used NPs (Cho 
and Irudayaraj, 2013; Medley et al., 2008; Shin et al., 2014). Multiplex detection 
combined with modern instrumentation enables multimodal analysis of several 
different analytes at once. The incoming approach represents the in vivo biosensors 
which connect non-invasive quantification with immediate real-time monitoring 
(Rong et al., 2017). 
Optical imaging may highly improve disease diagnosis and treatment as it 
determines the spread and localization of disease for guided intervention as well as 
positively confirms the site-specific drug delivery. Optical methods for NPs detection 
include fluorescence, bioluminescence, Raman spectroscopy and optical coherence 
tomography and can be successfully expoited both for in vitro and in vivo conditions 
(Biffi et al., 2015). Imaging of structural and functional information on molecular 
level makes NPs a valuable tool in biomedical research and the development of 
optically stable, bright, biocompatible and targeted nanoscale systems drives one of 
the fastest growing fields of nanotechnology (Parveen et al., 2012). The inner body 
environment constitutes a highly demanding area with various limitations for 
appropriate imaging and subsequent analysis. Thus, efforts are addressed to improve 
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tissue penetration with the use of near-infrared fluorescence which also ensures the 
correct interpretation of image analysis, while it overcomes the undesirable 
excitation of tissue autofluorescence (Hilderbrand and Weissleder, 2010). The novel 
platform represents the multimodal optical imaging which utilizes multifunctional 
NPs to combine optical imaging with the detection on different physical basis, such 
as magnetic resonance imaging, positron emission tomography or computed 
tomography (Biffi et al., 2015; Bradbury et al., 2012). 
All mentioned biomedical applications of NPs relate to both inorganic 
(metallic, silicon, semiconductor) and organic (polymers, liposomes) materials, 
however, inorganic NPs predominantly work as imaging and diagnostic agents while 
organic NPs are mostly employed in targeted delivery. Generally, NPs move 
medicine towards the personalized single system tailored to the individual needs with 
the combination of therapy and diagnostic imaging – so called theranostics (Ryu et 
al., 2014).  
3.4.2 Interactions of Nanoparticles In Vitro and In Vivo  
Reduction of all of the material spatial dimensions to nanoscale grants unique 
physicochemical properties to the resulting NPs. The source of their exceptional 
behavior is based on the dramatically increased surface area and therefore the raise of 
number of atoms located on the surface. This high surface to volume ratio evokes 
increased reactivity of NPs towards their environment which could be both favorable 
and undesirable. In any case, the immense need of determination of such interactions 
intensively grows when considering the application of NPs in highly-reactive 
biological environment. 
In vitro biocompatibility assessment of NPs must take into account a series of 
pitfalls which emerge from the high reactivity. The colloidal stability cannot be 
evaluated in the original carrier fluid (water, ethanol) but it must be related to the 
biological media containing mixture of proteins, nutrients, antibiotics, salts or 
buffers. Agglomeration tendencies may be significantly increased under these 
conditions (Bruinink et al., 2015; Catalano et al., 2015). Great influence also lies in 
the correct dosing of NPs as the unsuitable overdose may cause immense 
agglomeration which makes evaluation of NPs cytotoxicity and uptake by the cells 
difficult (Wittmaack, 2011a). Moreover, based on this knowledge it needs to be 
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emphasized that the right dose quantification should be performed in terms of 
reactive surface area rather than in volume concentration or total number of NPs 
(Rivera-Gil et al., 2013; Wittmaack, 2011b). The possible cross-reaction with 
analytes and dyes in biochemical viability assays and also interference with optical 
measurements can lead to misinterpretation of NPs cytotoxicity. The issue is 
summarized in excellent guidance publication for nanotoxicity testing by Ong et al. 
which also provides solutions for certain conflicts in measurements (Ong et al., 
2014). Optical properties such as photoluminescence are fundamental to serve the 
purpose of detection of specific NPs. Nevertheless, the interference with constituents 
of biological fluids in extra- and intracellular space may lead to significant 
photoluminescence decay or complete quenching (Khani et al., 2011; Zhang et al., 
2008). 
For in vivo applications, additional NPs interaction-based challenges emerge. 
Primarily, this includes unfavorable pharmacokinetics and biodistribution. Here 
comes into play the uptake by phagocytic mononuclear cells which removes NPs 
from the circulation and consequently causes their accumulation in spleen or liver. 
This effect can be minimized by decoration of the surface by polyethylene glycol 
chains (PEGylation) as a charge neutral and hydrophilic polymer (Hamidi et al., 
2006). There are two routes of clearance of non-biodegradable NPs from the body - 
renal and hepatic pathway. The ultrafiltration in kidneys is dependent on the size, 
charge and shape and, in a simplified way, only very small NPs of size ≤ 6 nm are 
able to pass through the pores in glomerulus (Zarschler et al., 2016). Any bigger NPs 
are eliminated through the liver where the degradation of NPs in the lysosomes of 
hepatocytes takes place (Briley-Saebo et al., 2004). Potential risk arises when the 
degradation is not possible or is significantly decreased which leads to the 
accumulation effect and activation of the cell death (Lovrić et al., 2005). When 
mentioning the size, it must be highlighted that the diameter of NPs in biological 
fluid significantly differs from the diameter of bare NPs. Resulting hydrodynamic 
diameter may be even several times bigger and is generated by the adsorption of 
biological components and formation of surface corona. 
Bio-corona or protein corona (PC) is established at the interface of the artificial 
material and biological environment. PC endows NPs with new biological identities 
which are substantially different from the original synthetic ones which only refer to 
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size, shape and chemistry (Monopoli et al., 2012). The formation of PC starts right 
after the exposure of NPs to the biological fluid with the adsorption of high-abundant 
proteins and then successively ensues the replacement by the proteins with higher 
affinities – so-called Vroman effect (Hirsh et al., 2013). Adsorption of proteins is a 
dynamic process and we distinguish two PC layers according to the dynamical and 
affinity aspects. Hard corona tightly bounds to the bare surface of NPs and its 
composition changes slowly in the range of several hours. Fast exchanging outer 
layer called soft corona consists mainly from components of a lower affinity (Casals 
et al., 2010) (Fig. 5).  
 
 
Figure 5 – Schematic representation of nanoparticle protein corona composition. 
Adopted from (Wolfram et al., 2014). 
 
The structure of PC highly affects the cellular uptake and intracellular 
trafficking of NPs (Guarnieri et al., 2011; Monteiro-Riviere et al., 2013) and  may 
also hinder the targeting ligand (Albanese et al., 2014; Salvati et al., 2013). 
Furthermore the conformational changes in adsorbed proteins can cause activation of 
unintentional signaling pathways (Deng et al., 2011). Moreover, comparative in vitro 
and in vivo experiments can be conflicted due to even subtle differences in 
composition of PC (Hadjidemetriou et al., 2015). On the other hand, the 
understanding of the processes on the interface can help to overcome limitations 
which are consequent upon the PC formation. Modification of the NPs surface by 
selected biomolecules can therefore induce the binding of the specific proteins of PC 
and enhance the desired properties of NPs (Prapainop et al., 2012). 
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3.4.3 Cellular Uptake and Trafficking of Nanoparticles 
PC-influenced change of NPs properties (size, charge, aggregation) express a 
direct linkage to alteration of the internalization of NPs into the cells. The amount of 
internalized NPs and the way of entry into the cells is highly specific and the 
experimental set-up requires very detailed procedure compliance to obtain consistent 
results. Presence or absence of PC strongly affects the uptake mechanism and 
consequently the rate of accumulation and intracellular fate of NPs (Catalano et al., 
2015; Guarnieri et al., 2011; Monteiro-Riviere et al., 2013). Additionally, PC is not 
the only decisive factor as internalization processes turn out to be dependent on cell 
type, charge, concentration and diameter of the NPs whether with or without PC 
(Calatayud et al., 2014; Perevedentseva et al., 2013; Yu et al., 2012). Considerable 
number of studies has been focused on understanding of the route of the NPs uptake 
and the correlation of such phenomena to their physicochemical properties. 
However, to define universal denominator which would predict the cellular behavior 
in relation to NPs characteristics is still far from being resolved since there is an 
immense amount of diverse studies those results simply cannot be jointly evaluated 
due to differences in experimental design.  
Recently, three main strategies are used for NPs intracellular delivery: passive, 
facilitated or direct (Damalakiene et al., 2013). The latter one involves specific 
physical or mechanical techniques which lead to direct transport of NPs into the 
intracellular space (microinjection, electroporation). Facilitated delivery is another 
designation for targeted delivery via marking the NPs surface by specific functional 
molecule and together with passive delivery represents a major challenge for 
nanotechnology to design tailored NPs with desired amount of internalization to the 
aimed cells. Up to date, the vast majority of studies incline to the theory that the 
active process of endocytosis is the main way of entry of NPs into the cells. Passive 
penetration through plasma membrane is still suggested for very small NPs which 
entry may be further facilitated by their positively charged surface that enables better 
adherence to the negatively charged cell membrane (Rothen-Rutishauser et al., 2006; 
Wang et al., 2012). However, such non-regulated pass through plasma membrane 
poses a risk of uncontrolled accumulation of NPs inside the cells or even membrane 
rupture leading to higher cytotoxicity (Treuel et al., 2013). Fortunately, the harmful 
passive penetration is negligible from the  perspective of the overall cellular uptake, 
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equally as the innocuous passive diffusion through the pore defect in intact plasma 
membrane (Damalakiene et al., 2013). It is suggested that these passive uptake 
mechanisms may play important role during long-term exposure to low NPs 
concentrations (Treuel et al., 2013).  
Endocytosis thus represents the dominant pathway of NPs uptake and further 
trafficking through intracellular space. General term of endocytosis encompass 
processes based on invagination of plasma membrane followed by forming of 
intracellular vesicles for final sorting (early endosomes), distribution (late 
endosomes) and degradation (lysozomes) of the exogenous material. Typically, 
endocytosis falls into two broad categories based on their specificity to the accepted 
material:  selective and non-selective mechanisms (Fig. 6). Selective processes 
involves receptor-mediated uptake called clathrin- and caveolin-dependent or 
independent endocytosis. Macropinocytosis (= phagocytosis in phagocytic cells) and 
micropinocytosis make up the group of non-selective mechanisms which are 
designated to ingestion of large-sized or dissolved small molecules, respectively. For 
the uptake of given type of NPs by the cells several distinct types of endocytosis may 
be used at the same time (Firdessa et al., 2014). Many efforts were put into 
correlation of the size of NPs to the type of endocytic pathway yet the outcomes are 
rarely uniform and often conflicting (Rejman et al., 2004; Yan et al., 2012). 
However, it was confirmed that small NPs (approx. 10 nm) need to accumulate on 
the plasma membrane in sufficient amount to be able to trigger the pit formation and 
therefore the endocytosis while large NPs (approx. 100 nm) do not need the previous 
accumulation to reach the same effect (Jiang et al., 2011, 2010). Based on this 
knowledge, all internalization studies must involve appropriate techniques for precise 
distinctions of incorporated NPs from membrane-attached NPs whereas neglecting 





Figure 6 – Illustrative scheme of possible nanoparticle uptake by different pathways 
of endocytosis. Adopted from (Papasani et al., 2012). 
 
Only very few studies were conducted to describe the process of metabolism or 
excretion of NPs from the cells. Biodegradable NPs are expected to be degraded in 
endosome-lysozomal vesicular complex (Barthel et al., 2014) and the metabolism is 
very often evaluated on the basis of decreased optical characteristics, primarily 
fluorescence. Nevertheless, for example very stable fluorescence quantum dots may 
exhibit only blue shift of their emission and do not give information about the extent 
of their degradation as they can be detected in vivo even after many months 
(Fitzpatrick et al., 2009). On the other hand, certain NPs do not undergo any type of 
degradation and the insufficient excretion cannot compensate the fast accumulation 
in cells which leads to higher cytotoxicity (Fucikova et al., 2014). Exocytosis of NPs 
is prevalently considered as a much slower process than endocytosis and the rate is 
dependent on the size of NPs – the larger size of incorporated NPs the longer it takes 
to remove them to the cell exterior (Iversen et al., 2011).  
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3.4.4 Quantum Dots and Silicon Based Nanoparticles 
Cellular imaging by fluorescence markers has been a challenge for 
nanotechnology at the end of the last century. Until that time, many dyes and contrast 
agents were unstable and unreliable in the terms of long-time detection. Considerable 
advancement was achieved when the focus aimed at the so-called quantum dots 
(QDs) which were firstly synthesized in early 1980‘s (Ekimov et al., 1985). QDs are 
heterogeneous semiconductor nanocrystals characterized by natural bright and long-
lasting fluorescence (photoluminescence). Other physicochemical parameters which 
predicted their biological fate include water solubility, small size and possible 
surface modification or coating. QDs usually consist of a colloidal core surrounded 
by one or more layers of coatings forming a QD shell. This shell prevents the core 
from leaching out the elements from the core, increases solubility and enables 
additional surface treatment by conjugation with various ligands (Derfus et al., 2004; 
Michalet et al., 2005; Zhang and Monteiro-Riviere, 2009).  
First and still successful QDs are constituted on the basis of cadmium (CdSe, 
CdTe, CdS) and their first biological study was carried out in 2004 with the high 
expectations of nontoxicity (Chen and Gerion, 2004). Unfortunately, a few years 
later considerable cytotoxicity was revealed and potential use of QDs based on 
cadmium for in vivo or long-term in vitro imaging was not recommended 
(Schwerdtle et al., 2010). However, QDs as imaging probes are still of special 
interest in biomedical research, especially in immunohistochemistry and ex vivo 
imaging (Tang et al., 2017), and their development aims at the utilization of non-
toxic elements for synthesis. 
Attractive chemical alternative for biomedical purposes represents the use of 
silicon (Si) which is a common trace element in a human body. Si-based NPs 
(SiNPs) may be in porous or crystalline form of pure or SiO2 (silica) material. All 
mentioned formulations are distinguished by the exceptional biocompatibility which 
is based on their natural slow degradation of Si into orthosilicic acid which is 
effectively excreted from the body through urine system when accumulated 
(Boguszewska-Czubara and Pasternak, 2011). The efficient intrinsic 
photoluminescence of SiNPs facilitates their detection without any necessary 
intervention into their structure or tagging the surface with a dye. Moreover, there are 
reports that SiNPs possess higher photostability than organic dyes usually used in 
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bioimaging (Shen et al., 2011). The origin of photoluminescence properties of SiNPs 
is probably dependent on quantum confinement and surface state effects and the 
emission is exhibited in the yellow-red part of the visible spectra based on their 
chemical purity (Fucikova et al., 2011). With the quantum yield around 10%, there is 
a sufficient chance of their detection by the means of conventional fluorescence 
microscopy. Moreover, the lifetime of excited state reaches to 100 µs and thus makes 
it possible to better resolve the signal from the surrounding noise with the 
autofluorescence lifetime of ca 5 ns (Fucikova et al., 2011; Ostrovska et al., 2016). 
Many studies have already proposed different forms of SiNPs for in vitro and vivo 
applications, mainly in the field of bioimaging (Korhonen et al., 2016; Zhong et al., 
2015). 
3.4.5 Gold and Platinum Nanoparticles 
As it is generally known, metallic materials have accompanied the mankind 
since ancient time (preparation of tools, decorative use). Unlike base metals, noble 
metals exhibit very important characteristics for them to be utilized in medicine. 
First, there is the unique resistance to corrosion in liquid or gaseous environment 
even in high temperatures and second, it is their non-reactivity with other substances. 
Besides that, the most well-known noble metals – gold (Au), silver (Ag) and 
platinum (Pt) demonstrate antimicrobial activities which altogether with their 
physical attributes made them suitable for treatment of infections already in ancient 
era (Pal et al., 2014).   
Scaling the size of noble metals to nano level gives rise to the new properties 
such as unique optical feature – localized surface plasmon resonance which enables 
their easy optical detection based on emission of light of specific wavelength after 
excitation. This size- and shape-dependent property causes different coloring of 
noble metal colloids (Eustis and El-Sayed, 2006). Nano-scaling also allows extensive 
decoration of the surface of noble metal nanoparticles with peptides, antibodies or 
tumor markers which finds use especially in cancer diagnosis and treatment (Conde 
et al., 2012). Other than medical applications of noble metal NP include catalysis, 
photography, non-linear optics and photonics (Rai et al., 2016). 
Gold is undoubtedly the most important noble metal from historical and 
medicinal point of view. As a bulk material, gold exhibits series of antimicrobial and 
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antitumor activities and is often present in different kinds of medical devices and 
implants (Kim et al., 2017; Svedman et al., 2006). Owing to this favorable activities, 
gold in a form of NP (AuNP) can often act in multimodal way when used in 
biomedicine. Simultaneously, AuNP can work as therapeutics, diagnostic tools and 
drug carriers mainly in cancer treatment. When used for imaging purposes, AuNP 
profit from their capability of prolongation of the retention time in the body while 
enhancing contrast for more precise visualization of the tumor (Hainfeld et al., 2006). 
Conjugates of AuNP with anticancerous drug increase efficacy of the treatment in 
comparison to the drug itself which was reported in the work of Madhusudhan et al. 
(2014) for the conjugates of doxorubicin in cervical carcinoma. Similarly AuNP act 
as vehicle for drug delivery in anti-HIV treatment and also HIV-1 antigen detection 
(He et al., 2014).  Different application of AuNP represents the analysis of cell 
adhesion in tissue engineering e.g. by the means of surface-enhanced Raman 
spectroscopy (Coluccio et al., 2016) or improvement of cell adhesion to the material 
by coating of its surface (Slepička et al., 2013). 
Platinum NP (PtNP) have received a great deal of attention for their antioxidant 
activity. Such ability can be used in reducing of cellular oxidative stress which stands 
behind many inflammatory-induced diseases (neurodegenerative diseases, asthma, 
diabetes etc.) or in reducing of bone loss (Rai et al., 2016). Peroxidase-like activity 
of some PtNP nanohybrids (e.g. with graphen oxide) are promising systems which 
could replace existing colorimetric immunoassays due to possible direct detection or 
higher specifity to cancer cells (Kim et al., 2014; Zhang et al., 2014). Moreover, 
Manikandan et al. (2013) reported successful phototermal treatment by different 
sizes of PtNP of Neuro 2A cell lines. 





4 Aims of the Thesis 
 
 
I. To evaluate biological responses of different cell types to the ultra-fine 
grain titanium with different surface treatment and to provide overall 
insight into the cell adhesion and proliferation for subsequent pre-clinical 
trials. 
 
II. To describe elemental reactions of human cells to fluorescence silicon-
based nanoparticles of different types with regard to their cytotoxicity and 
internalization into cells in presence or absence of proteins in cultivation 
medium. 
 
III. To optimize and standardize protocols for advanced microscopic imaging 
of fluorescence silicon nanoparticles in cell cultures. 
 
IV. To determine the viability of human osteoblasts in the presence of gold 















5 Materials and Methods 
 
Materials and methods are described in detail in publications A, C, D, G. The 
enclosed list contains methods that were performed by author of this thesis. Materials 
and methods of all unpublished data (B, E, F) are described below in detail (see in 
5.1, 5.2, 5.3). 
 
Tested materials: 
 Ultra-fine grain titanium (A, B) 
 Silicon quantum dots – T1100 (C, D, F) 
 Silicon quantum dots – T1050 (C) 
 Silicon-carbide nanoparticles (E) 
 Golden and platinum nanoparticles (G) 
 
Culture of cells: 
 Human osteoblast-like cell line SAOS-2 (A-G) 
 Human mesenchymal stem cells (A) 
 Human dermal fibroblasts (B) 
 Spontaneously immortalized human keratinocyte cell line HaCaT (B) 
 
(Immuno)fluorescently stained structures: 
 nuclei (DAPI staining) (A-C) 
 actin stress fibers (phalloidin Alexa488) (A, B) 
 focal adhesions (vinculin) (A, B) 
 late endosomes (M6PR) (F) 
 lysosomes (LAMP2) (F) 
 
Cell Imaging by Light Microscopy (A-G) 
 
Cell Imaging by Fluorescence Wide-field Microscopy (A-C, E, F) 
 
Cell Imaging by Fluorescence Confocal Microscopy (C, F) 
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Live-cell Imaging (F) 
Advanced Image Analyses: 
 Cell number determination (A, B) 
 Cell area determination (A, B) 
 3D reconstruction of confocal microscope images (C, F) 
ImageJ (Rasband, W.S., ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, 




 Metabolic activity assessment (MTS assay) (A-E, G)  
 Enzyme-linked immunosorbent assay (ELISA) - determination of the amount 
of inflammatory cytokines (IL-8 a TNF-α) and collagen type I (B) 
 
Statistical Analyses: 
 Shapiro–Wilk test (A-D, G) 
 Nonparametric Wilcoxon matched pairs test (A-D, G) 
 ANOVA with a subsequent post-hoc Fischer LSD test (A-D, G) 
 Pearson‘s correlation coefficient (F) 
 Manders split coefficients (F) 
 STATISTICA Software (StatSoft, Czech Republic) and ImageJ (Rasband, W.S., ImageJ, U.S. 













5.1 Methods of PART I. - Unpublished Data (B) 
5.1.1 Evaluation of Biological Responses of Human Dermal Fibroblasts and 
Human Keratinocyte Cell Line to Ultra-Fine Grain Titanium 
Cell Cultivation 
Normal human dermal fibroblasts (NHDF) were obtained from the skin of 
donors undergoing cosmetic plastic after giving the written consent. After 
isolation from the dermis, NHDF were cultured in Dulbecco‘s modified 
Eagle‘s medium (DMEM) (Biochrom, UK) supplemented with 10% heat-
inactivated fetal bovine serum (FBS) (HyClone, USA), 0.3 mg ml
-1
 glutamine 
(Biochrom, UK), 100 U ml
-1
 penicillin (HyClone, USA), 0.1 mg ml
-1
 
streptomycin (HyClone, USA), 10 mg ml
-1
 gentamicin (Biowest, France) and 
1% non-essential amino acids (GE Healthcare, UK). NHDF were seeded at a 
density of 10 000 cells per cm
2
 and cultured up to the 5th passage for 
experimental purposes. 
Immortalized human keratinocyte cell line HaCaT (Contipro, Czech Republic) 
was cultured in DMEM (Sigma-Aldrich, USA) supplemented with heat-
inactivated 10 % FBS (PAA, Canada), 10 mg ml
-1
 gentamicin (Biowest, 
France) and 0.3 mg ml
-1
 glutamine (Biochrom, UK). The cells were seeded at a 




All following procedures are identical to those described in detail in 
Publication A. 
 
5.1.2 Detection of Inflammatory Cytokines IL-8 and TNF-α after Exposure of 
Human Blood Samples to Ultra-Fine Grain Titanium 
Sample Preparation 
Heparinized freshly collected blood samples of 6 ml volume were obtained 
from four healthy donors after giving written consent. Every blood sample was 
diluted with 6 ml Roswell Park Memorial Institute media (RPMI). 1 ml of the 
diluted blood was added to ultra-fine grain titanium (UFG-Ti) samples after 
their proper sterilization (Publication A). The same amount of diluted blood 
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was placed on polystyrene (PS) control and to lipopolysaccharide (1 and 10 μg 
ml
-1
) representing positive control. Diluted blood was incubated with UFG-Ti 
samples for 6 hours at 37°C. After 6 hours incubation, diluted blood was 
centrifuged at 300xg for 6 minutes and supernatants were collected on ice and 
frozen at -80°C.  
Cytokine Assessment 
On the day of the assessment, supernatants were let to thaw at the room 
temperature and further used in enzyme-linked immunosorbent assay (ELISA) 
for IL-8 and TNF-α detection (ELISA To Go, eBioscience, USA). Procedure 
was realized according to manufacture protocol. Optical density was measured 
using a microplate reader (Synergy H1, BioTek) at 450 nm subtracting the 
background at 540 nm. 
 
5.1.3 Detection of Collagen Type I in Collected Cultivation Media after 
Cultivation with Ultra-Fine Grain Titanium 
Sample Preparation 
The SAOS-2 cells (DSMZ, Germany) were seeded onto UFG-Ti samples and 
PS control in the same way as it is described in Publication A. Cells were 
incubated at 37°C in humidified 5% CO2 atmosphere for the time lapse of 14 
days. On 5th, 8th, 12th and 14th day of incubation, previous cultivation media 
was collected and frozen at -80°C. Fresh new cultivation media was added to 
the cells until the time point of next collection.  
Collagen Type I Assessment 
On the day of the assessment, frozen samples of cultivation media were let to 
thaw at the room temperature. Before the procedure all samples were diluted 
1:100 with reagent diluent belonging to the used kit and then processed in 
enzyme-linked immunosorbent assay (ELISA) for Human Pro-Collagen I 
α1/COLIA1 detection (DuoSet ELISA, R&D Systems, USA). Procedure was 
realized according to manufacture protocol. Optical density was measured 
using a microplate reader (Synergy H1, BioTek) at 450 nm subtracting the 
background at 540 nm. 
42 
 
5.2 Methods of PART II. – Unpublished Data (E) 
5.2.1 Evaluation of Cytotoxicity of Silicon-Carbide Nanoparticles 
Cell Cultivation  
The SAOS-2 cells (DSMZ, Germany) were cultured in DMEM (Gibco, USA) 
and supplemented with 10 000 U ml
-1
 penicillin (Biosera, France), 10 mg ml
-1
 
streptomycin (Biosera, France), 0.3 mg ml
-1
 glutamine (Biosera, France) and 
for purposes of initial seeding of the cells also with 15% heat-inactivated FBS 
(Gibco, USA). For experimental purposes, cells were seeded at a density of 10 
000 cells per cm
2
 onto a 96-well plate in triplets (100 µl) and further cultured 
for 24 hours in a humidified 5% CO2 atmosphere at 37°C. 
Two types of cultivation media were used further in the experiments – DMEM 
with 10 000 U ml
-1
 penicillin, 10 mg ml
-1
 streptomycin and 0.3 mg ml
-1
 
glutamine with no serum proteins (serum-free) or supplemented with 5% FBS 
(serum-supplemented). The final concentrations of silicon-carbide 
nanoparticles (SiCs) in the media used for cell treatment consisted of 250 µg 
ml
-1
, 100 µg ml
-1
 and 50 µg ml
-1
. The cells were gently rinsed with phosphate 
buffered saline (PBS) prior to the addition of the cultivation media containing 
SiCs. Subsequently, the cells were cultivated to different time points depending 
on the time of assessment (24 hour or 48 hours). In the case of the serum-free 
media, an additional volume of 50 µl of the medium with 5% FBS was added 
after 6 hours of cultivation and cultivated for an additional 18 hours or 42 
hours (for total cultivation time 24 hours or 48 hours respectively).  
Cytotoxicity Assessment 
The cytotoxicity of various concentrations of SiCs in different media was 
assessed by means of the measurement of the metabolic activity of the cells at 
24 and 48 hours following the addition of SiCs to the cells. Assessment was 
performed by means of MTS assay (Cell Titer96® AqueousOne, Promega, 
USA). The principle of this colorimetric assay is described in detail in 
Publications A, C and D. The assay was performed according to the 
manufacture protocol. The cells were rinsed three times with PBS and then 
incubated for 2 hours with an MTS reagent diluted DMEM with 5% of FBS. 
Optical density was measured using a microplate reader (Synergy H1, BioTek) 
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at 490 nm subtracting the background at 655 nm. The subtraction of blank 
values was conducted for each type of medium separately. All the results 
obtained were compared to the results of the control cells cultivated in a 
medium supplemented with 5% FBS; the results were expressed as 
percentages. 
 
5.3 Methods of PART III. - Unpublished Data (F) 
5.3.1 Colocalization of Selected Endocytic Cell Structures with Silicon Quantum 
Dots 
Cell Cultivation 
The SAOS-2 cells (DSMZ, Germany) were cultured in DMEM (Gibco, USA) 
and supplemented with 10 000 U ml
-1
 penicillin (Biosera, France), 10 mg ml
-1
 
streptomycin (Biosera, France), 0.3 mg ml
-1
 glutamine (Biosera, France) and 
for purposes of initial seeding of the cells also with 15% heat-inactivated FBS 
(Gibco, USA). For experiments, the cells were seeded at a density of 10 000 
cells per cm
2
 onto cell imaging cover glass with 8 chambers in doublets (400 
µl) and further cultured for 24 hours in a humidified 5% CO2 atmosphere at 
37°C. 
Silicon quantum dots (SiQDs) went through the evaporation process prior to 
the final dilution in appropriate cultivation media. Procedure is described in 
detail in Publication C. Two types of cultivation media were used – serum-free 
and serum-supplemented with 5% of FBS (see 5.2.1. Cell Cultivation). Final 
concentration of SiQDs in both media was 200 µg ml
-1
. The cells were gently 
rinsed with PBS prior to the addition of the cultivation media containing SiQDs 
(300 µl). Subsequently, the cells were cultivated to different time points (1 
hour, 4 hours or 24 hours). In the case of 24 hours experiment, an additional 
volume of 150 µl of media with 15% FBS was added to the serum-free media 
and the equal volume of 5% FBS media was added to the serum-supplemented 




Fluorescent Staining of Cells 
After 1, 4 and 24 hours, the cells were gently washed 3 times with PBS and 
immediately fixed in 4 % paraformaldehyde. Then, selected endocytic 
structures were marked by following primary antibodies - mouse monoclonal 
anti-M6PR (2G11) (1:200, Abcam, UK) for late endosomes and mouse 
monoclonal anti-LAMP 2 (1:50, Abcam, UK) for lysosomes. Secondary 
antibody Alexa Fluor 568-conjugated goat anti-mouse (1:1000, Thermo Fisher, 
USA) was used for visualization of all mentioned endocytic structures. 
Imaging of Fluorescently Stained Cells  
2D and 3D images of the stained cells with SiQDs were acquired using 
Olympus IX83 microscope (Olympus, Japan) equipped with confocal scanning 
unit CSU-W1 (Yokogawa, Japan) with dual monochrome digital sCMOS 
camera for multi-channel imaging (Olympus, Japan). The SiQDs were excited 
using 405 nm diode laser with the exposition time of 2000 ms and the emission 
was detected using Cy5 700-775 nm filter. For the detection of stained 
organelles, the excitation 561 nm of diode laser was used. Emission was 
detected by TRITC 609-654 nm filter. More 2D images were acquired with 
respect solely to the 24 hour experiments by means of a Leica TCS SP8X 
confocal laser scanning microscope (Leica Microsystems). The SiQDs were 
excited using a pulse continuum white light laser (475–499 nm) and emissions 
were collected via a hybrid detector at 700–795 nm. The elimination of cell 
autofluorescence from SiQDs signals was achieved by the gating of signal 
detection with a 5 ns delay from the excitation pulse. Multiple line 
accumulation scanning and prolonged pixel dwell were set so as to allow for 
the more intense and precise imaging of the SiQDs. All the confocal 3D images 
were acquired by means of a Leica DFC365 FX monochrome digital CCD 
camera. 
All 2D and 3D images were further analyzed by means of Fiji software 
(Schindelin et al., 2012). The same software with JaCoP plugin was also used 
for numerical interpretation of colocalization (signal overlap). Specifically, 




5.3.2 Live Imaging of Cells Interacting with Silicon Quantum Dots 
Cell Cultivation 
The SAOS-2 cells (DSMZ, Germany) were cultured in McCoy‘s 5A medium 
without phenol red (HyClone, USA) supplemented with heat-inactivated 15 % 
FBS (GE Healthcare, UK), 10 000 U ml
-1 
penicillin (Sigma-Aldrich, USA) and 
10 µg ml
-1 
streptomycin (Sigma-Aldrich, USA). For the experimental purposes, 
the cells were seeded at a density of 15 000 cells per cm
2
 onto cell imaging 
dish with 145 µm glass bottom (500 µl) and further cultured for 24 hours in a 
humidified 5% CO2 atmosphere at 37°C. 
SiQDs went through the evaporation process prior to the final dilution in 
appropriate cultivation media. Procedure is described in detail in Publication C. 
Final concentration of SiQDs in cultivation media was 100 µg ml
-1
. The cells 
were gently rinsed with PBS prior to the addition of the cultivation media 
containing SiQDs.  
Live Imaging 
Right after the addition of SiQDs, the cells were transferred into pre-heated 
stage top chamber, which maintain stable temperature (37°C), humidity and 
5% CO2 level for incubation stability during the imaging (OKOlab, Italy). 
Chamber was placed onto the stage of Nikon TE 2000E-C1si microscope 
(Nikon, Japan). SiQDs were excited with fluorescence wide-field 120W 
Mercury Vapor Short Arc LAMP through 330 – 380 nm UV2A filter cube with 
G2A emission filter (590 nm). Exposition time was set to 10 seconds and for 
more intense signal, also gain was 4 times increased. Images were acquired 
with Nikon DS-Qi1Mc digital CCD camera (Nikon, Japan). First image was 
taken after 30 minutes from SiQDs addition and then after every 30 minutes 
until cell were still alive. Simultaneously, DIC (Nomarski) phase contrast 
images were acquired. Further image analysis was realized in NIS-Elements 






In order to retain the consistency of the topics, the thesis is divided into four 
parts. Each of them summarizes publications and other unpublished results related to 
their common topic. All parts correspond to the aims of the thesis.  
Part I is focused on different types of biological testing of ultra-fine grain titanium. 
Part II focuses on biological evaluation of silicon nanoparticles of different origin.  
Part III sums up the work on advanced visualization of silicon nanoparticles inside 
the cells. 
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6.1 PART I: Ultra-Fine Grain Titanium (A, B) 
Part I of the thesis describes fundamental interactions of cells in direct contact 
with ultra-fine grain titanium (UFG-Ti) with different surface treatment. This 
novel form of titanium with superior mechanical properties belongs to a new 
generation of traditionally used titanium dental implants. Such material has a 
potential in fabrication of long-term dental implants which can ensure stable 
performance in load-bearing conditions. Although pure titanium excels with its 
unique biocompatibility, new process of manufacture may cause unexpected change 
in cell responses. Verification of cytocompatibility, proper cell adhesion and non-
inflammatory behavior is therefore crucial for any following pre-clinical trials. 
Moreover, surface topography is of capital importance in initial cell adhesion and 
further proliferation and differentiation. Hence, experiments in PART I also focus on 
feedback evaluation of different surface treatment and subsequent suggestions on 
modifications for practical application. 
Publication A depicts biological responses of two types of human cells 
cultivated on six types of UFG-Ti – osteoblasts SAOS-2 (osteosarcoma-derived cell 
line) and mesenchymal stem cells. Monitored parameters include cell proliferation, 
cell area, metabolic activity, cell morphology and adhesion at two different time 
points (2 hours and 48 hours). Additionally, further unpublished work (B) follows up 
the same experimental set-up with another two types of human cells – primary 
dermal fibroblasts and keratinocytes HaCaT (skin-derived aneuploid transformed cell 
line). Later on, determination of production of two inflammatory cytokines (IL-8 and 
TNF-α) provided elemental insight into immunogenicity of UFG-Ti. Influence of 
surface topography of UFG-Ti on cell ECM production was also marginally detected 
by measuring the amount of collagen type I in cultivation media during long time 
cultivation of SAOS-2 cells. 
This research is based on cooperation of biological, mechanical and chemical 
sectors. In publication A, biological part was performed by the author of the thesis 
while other work was done by colleagues from COMTES FHT a.s., Dobřany 
(fabrication of UFG-Ti samples, mechanical characterization), Institute of Physics, 
Academy of Sciences of the Czech Republic, Prague (topography characterization) 
and Institute of Macromolecular Chemistry, Academy of Sciences of the Czech 
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Republic, Prague (wettability measurement). Unpublished work (B) was performed 
by the author of this thesis. 
 
 
6.1.1 Publication A: Biological evaluation of ultra-fine titanium with improved 
mechanical strength for dental implant engineering 
Lucie Ostrovská, Lucie Vištejnová, Jan Džugan, Peter Sláma, Tomáš Kubina, Egor 
Ukraintsev, Dana Kubies, Milena Králíčková, Marie Hubálek Kalbáčová (2016): 
Biological evaluation of ultra-fine titanium with improved mechanical strength for 
dental implant engineering. Journal of Materials Science 51, 3097-3110. IF = 2.993 
Grain refinement belongs to the new approaches in improvement of mechanical 
characteristics of commercially pure titanium, which is used for dental and 
orthopedic implants for decades. Refining the basal grain size of titanium to 
nanoscale can extend the longevity and enhance resistance to the long-term loading 
stress of the final product. Additionally, when developing new functional implant, 
surface characteristics must be taken into account. For better acceptance of the 
implant by the organism it is crucial to stimulate cell attachment and further cell 
proliferation on the surface which also help to prevent bacterial infection in the 
interface. Remodelation of the implant surface to mimic extracellular environment of 
the bone tissue can be achieved by mechanical or chemical techniques. 
The aim of this publication was to evaluate the cytocompatibility of UFG-Ti 
samples fabricated by the ECAP-Conform process, which is one of the most 
developed techniques for metal nanostructuring. Three different grain sizes Z (≤ 1 
µm), M (4.61 µm) and S (30 µm) a two types of mechanical surface treatment - 
polishing (p) and grinding (g) were the variables of the manufacturing. Thus, six 
types of UFG-Ti samples were evaluated, i.e., Zp, Zg, Mp, and Mg, representing the 
new titanium materials with improved mechanical properties, and Sp and Sg, 
representing the original Ti material. Topographical and mechanical characterization 
of individual UFG-Ti samples is illustrated in Fig. 3 in publication A. Polystyrene for 
cell cultivation was used as a control material (PS control). Experiments were 
performed with the human osteoblast-like cell line SAOS-2 and human mesenchymal 
stem cells (hMSCs). Cells were seeded on sterilized UFG-Ti samples and after 2 and 
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48 hours the cell number and cell area were evaluated. At 48 hours only, morphology 
and focal adhesions (SAOS-2 cells only) of the cells were examined together with 
metabolic activity measurement by MTS assay. 
During the first 2 hours, number of SAOS-2 cells adhered to the surface of all 
UFG-Ti samples was significantly higher compared to the number of cells on PS 
control (Fig. 5a in publication A). Significant difference remained even after 48 
hours although the rate of cell number increase was not so pronounced suggesting 
successive slower growth of SAOS-2 cells on UFG-Ti samples (Fig. 5c in 
publication A). From the initial adhesion, reported area of SAOS-2 cells cultivated 
on UFG-Ti samples was smaller compared to the cells on PS control, yet the 
differences were mostly not significant. However, differences accentuated with the 
time and after 48 hours, SAOS-2 cells grown on UFG-Ti samples evinced 
approximately 20% cell area reduction in comparison to the control cells (Fig. 6b in 
publication A). Despite the smaller size, morphology of SAOS-2 cells after 48 hours 
cultivation on UFG-Ti samples displayed the same cuboidal-like shape like the cells 
on PS control. (Fig. 7b,c in publication A). Interestingly, the cells cultured on ground 
samples displayed noticeable focal adhesion plaques (Fig. 8e–g in publication A) on 
the extensions of the cells while on polished samples focal adhesions were localized 
on the basal pole of the cells. Thus, cells grown on polished samples displayed strong 
similarity with the cells cultured on the PS control (Fig. 8b–d in publication A). No 
significant difference in metabolic activity was observed between the UFG-Ti 
samples and the PS control and among UFG-Ti samples (Fig. 4a in publication A). 
hMSCs showed some differences in their interactions with UFG-Ti. The slower 
increase in cell number on UFG-Ti samples than on the PS control was even more 
pronounced (Fig. 5d in publication A), which led to the lowered cell number on the 
UFG-Ti samples after 48 h in comparison to the PS control. The same trend was 
observed in cell area evaluation where the cell size differences on UFG-Ti samples 
versus PS control enlarge with the time. The cell areas of hMSCs cultivated on UFG-
Ti after 48 hours were almost 50% smaller in comparison to PS control (Fig. 6c in 
publication A). Unlike SAOS-2 cells, hMSCs cultured on ground samples displayed 
noticeable elongation and filopodia extensions. Polished samples enabled the growth 
and spreading of hMSCs in all directions; thus, their morphology varied (Fig. 7e,f in 
publication A). Visualization of focal adhesion was not realized with hMSCs. Slight 
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decrease in metabolic activity was observed for ground M and S samples, otherwise 
no differences compared to PS control and among samples were observed (Fig. 4b in 
publication A). 
This publication evaluated short-time biological responses of SAOS-2 cells and 
hMSCs to newly developed UFG-Ti. We demonstrated that this material is suitable 
for the growth of both cell types, yet osteoblasts prosper on it even more; thus, UFG-
Ti demonstrated its potential for future bone implant development. 
 
 
6.1.2 Unpublished data (B): Evaluation of Biological Responses of Human 
Dermal Fibroblasts and Human Keratinocyte Cell Line to Ultra-Fine 
Grain Titanium 
Previous findings from the publication A confirmed the suitability of newly 
developed UFG-Ti for the growth and proliferation of human osteoblasts SAOS-2 
and hMSCs. In the following work, we verified whether such material can be also 
used as a substrate for the growth of human dermal fibroblasts (NHDF) and human 
keratinocytes cell line (HaCaT). The results of publication A revealed considerable 
influence of surface topography on different cell types attachment, morphology and 
rate of proliferation. Dermal fibroblasts and especially keratinocytes differ from 
previously used cell types by their preference in the substrate quality, as they grow 
on much softer surfaces in their natural environment. As it was mentioned, UFG-Ti 
has a potential mainly in future bone or dental implant development. However, skin-
penetrating devices (e.g. intraosseous transcutaneous amputation prostheses) are 
generally fabricated from titanium and its alloys and they struggle with the proper 
attachment of the cells on the interface. Confirmation of the cytocompatibility of 
UFG-Ti to dermal fibroblasts and keratinocytes may expand its scope of activity in 
the field of implantology. 
All experiments were performed with the same UFG-Ti samples under the 
same conditions and experimental set-up as it is described in Publication A. 
Visualization of focal adhesion was not evaluated.  
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From the beginning, the number of NHDF cells adhered to the surface of UFG-
Ti samples was very similar to PS control (Fig. B1). Yet after 48 hours the number of 
cells on some samples (especially on both S samples) was lower compared to PS 
control suggesting the significantly slower growth of NHDF. The same trend as in 
publication A was observed with cell area evaluation. After 2 hours, there were no 
differences in NHDF size between UFG-Ti samples and PS control, not even among 
the samples, except for Sp sample. But with the time, cells on UFG-Ti samples 
showed significant cell area reduction when compared to the cells on PS control (Fig. 
B2). Similarly to hMSCs, NHDF expressed the dependence of cell morphology on 
surface topography. NHDF seeded onto polished samples displayed variable shapes 
and grew mostly in multi-layers, while the cells on ground samples grew uniformly 
in one layer elongated in one direction (Fig. B4b,c). Metabolic activity of cells on all 
UFG-Ti samples showed only small differences from the cells cultivated on PS 
control (Fig. B3), however, no cytotoxic effect (reduction under 75% control) 









Figure B1: Cell number of dermal fibroblasts (NHDF) after 2 and 48 h of 
cultivation on UFG-Ti samples. a) values of cell number/cm
2
, b) relative values 
expressed as a percentage of PS control (dashed line). Asterisk (*) means a 
significant difference from PS control (Wilcoxon matched-pairs test, p ˂ 0.05). 
Groups marked with different lower-case letters (2 h) or with different upper-case 
letters (48 h) express significant inter-group difference within samples (ANOVA, 






Figure B2: Cell area of dermal fibroblasts (NHDF) after 2 and 48 h of 
cultivation on UFG-Ti samples. Relative values expressed as a percentage of PS 
control (dashed line). Asterisk (*) means a significant difference from PS control 
(Wilcoxon matched-pairs test, p ˂ 0.05). Groups marked with different lower-case 
letters (2 h) or with different upper-case letters (48 h) express significant inter-group 




Figure B3: Metabolic activity of dermal fibroblasts (NHDF) after 48 h of 
cultivation on UFG-Ti samples. Relative values expressed as a percentage of PS 
control (dashed line). Asterisk (*) means a significant difference from PS control 
(Wilcoxon matched-pairs test, p ˂ 0.05). Groups marked with different letters 
express significant inter-group difference within samples (ANOVA, LSD post hoc 
test, p ˂ 0.05). 
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Figure B4: Representative images of cells on different substrates after 48 h of 
cultivation. Dermal fibroblasts (NHDF) (a–c) and keratinocytes HaCaT (d–f) on PS 
control (a, d), polished sample (b, e), ground sample (c, f). Actin cytoskeleton 
stained by phalloidin-AF488 (green), nucleus stained by DAPI (blue), vinculin as a 
protein of focal adhesions stained by indirect immunofluorescent staining (secondary 












Specific growth of HaCaT cells made the cell number and cell area very 
difficult to assess. Keratinocytes form tight multi-layer clusters; thus; the single cell 
recognition is greatly intricate. After 2 hours, the number of HaCaT cells on polished 
UFG-Ti samples was similar to the number of cells on PS control while slightly more 
cells were found on ground samples (Zg and Sg significantly). Accuracy of the 
following cell number measurement at 48 hours was negatively influenced by the 
increase of the amount of the cells in clusters which is expressed by quite large 
deviations (Fig. B5a). Growth of the cells was also probably slowed down as it is 
illustrated in Fig. B5b. Cell area after 2 hours was not assessed due to insufficient 
size of the HaCaT cells for measurement. After 48 hours though, the size of the cells 
on UFG-Ti samples showed no difference to the cells on PS control (Fig. B6). No 
specific morphology alterations were observed on UFG-Ti samples. However, the 
way of growth was dependent on the surface – on polished samples HaCaT cells 
formed large high-dense layers similar to PS control and minimum cells was found 
around in isolated clusters (Fig. B4e). On contrary, HaCaT cells cultivated on ground 
samples formed many smaller clusters not binding to each other (Fig. B4f). Values of 
metabolic activity of HaCaT cells on all UFG-Ti samples were lower than on PS 
control, yet the decrease was not statistically significant (Fig. B7).  
This work extended our knowledge about shot-time cell biological responses to 
UFG-Ti. Characteristics of dermal fibroblasts on UFG-Ti samples resemble the 
results we obtain previously from mesenchymal stem cells.  Keratinocytes did not 












Figure B5: Cell number of keratinocytes (HaCaT) after 2 and 48 h of cultivation 
on UFG-Ti samples. a) values of cell number/cm
2
, b) relative values expressed as a 
percentage of PS control (dashed line). Asterisk (*) means a significant difference 
from PS control (Wilcoxon matched-pairs test, p ˂ 0.05). Groups marked with 
different lower-case letters (2 h) or with different upper-case letters (48 h) express 










Figure B6: Cell area of keratinocytes (HaCaT) after 48 h of cultivation on UFG-
Ti samples. Relative values expressed as a percentage of PS control (dashed line). 
Asterisk (*) means a significant difference from PS control (Wilcoxon matched-pairs 
test, p ˂ 0.05). Groups marked with different letters express significant inter-group 





Figure B7: Metabolic activity of keratinocytes (HaCaT) after 48 h of cultivation 
on UFG-Ti samples. Relative values expressed as a percentage of PS control 
(dashed line). Asterisk (*) means a significant difference from PS control (Wilcoxon 
matched-pairs test, p ˂ 0.05). Groups marked with different letters express 




6.1.3 Unpublished data (B): Detection of Inflammatory Cytokines IL-8 and 
TNF-α after Exposure of Human Blood Samples to Ultra-Fine Grain 
Titanium 
Assessment of cytocompatibility of UFG-Ti with four different cell types 
concluded the first cell part of UFG-Ti biological evaluation. Subsequent 
experiments aimed to the determination of the UFG-Ti tendency to the induction of 
inflammation. To mimic the inner body environment, freshly collected blood 
samples were used for the assessment. Production of two representative 
inflammatory cytokines in blood plasma – interleukin 8 (IL-8) and tumor necrosis 
factor α (TNF-α) was measured after short-time incubation with UFG-Ti samples. 
Blood samples were taken from four healthy donors and then each one of them 
was cultivated with all six UFG-Ti samples for 6 hours. Polystyrene for cell 
cultivation was used again as a control material (PS control). Lipopolysaccharide 
(LPS) was used as a positive control of inflammation process. Afterwards, 
supernatants from centrifuged blood samples were collected and frozen until the day 
of the measurement. The evaluation of the amount of produced cytokines was 
performed for every donor separately and then average values from all donors were 
used for the final determination. 
The results for IL-8 from all the donors were considerably similar (Fig. B8a). 
Summary evaluation revealed significant increase in the production of IL-8 on all 
UFG-Ti samples than on PS control. Moreover, the surface topography of UFG-Ti 
showed a very strong influence on the IL-8 production. Significantly higher amount 
of IL-8 was detected on ground samples compared to polished samples. While all the 
polished samples exhibited very similar values of IL-8 amount, the Zg sample 
significantly exceeded the other two ground samples in the produced amount of IL-8 
(Fig. B8b). It should be noted that none of the UFG-Ti samples increased the IL-8 
production to the level of inflammatory values (LPS).  
Similar trend was observed also in TNF-α measurement. All UFG-Ti samples 
induced the TNF-α production significantly more than PS control. Noticeable 
difference was also found between the amount of TNF-α on polished and ground 
samples. Ground samples increased the TNF-α production more than polished 
samples, yet the difference was not statistically significant (Fig. B9b). In this case, 
60 
 
large standard deviations were caused by the extensively different reactions of the 
donors (Fig. B9a). Eventually, none of the UFG-Ti samples increased the TNF-α 
production to the level of inflammatory values (LPS).  
In this work, we acquired brand new information about the immunogenicity of 
UFG-Ti. Based on the results, inflammatory reaction to the substrate was detected, 






















Figure B8: Production of inflammatory cytokine IL-8 after 6 h incubation with 
UFG-Ti samples. a) Results obtained from every donor separately, b) final average 
values from all donors. Asterisk (*) means a significant difference from PS control 
(Wilcoxon matched-pairs test, p ˂ 0.05). Groups marked with different letters 
express significant inter-group difference within samples (ANOVA, LSD post hoc 













Figure B8: Production of inflammatory cytokine TNF-α after 6 h incubation 
with UFG-Ti samples. a) Results obtained from every donor separately, b) final 
average values from all donors. Asterisk (*) means a significant difference from PS 
control (Wilcoxon matched-pairs test, p ˂ 0.05). Groups marked with different letters 
express significant inter-group difference within samples (ANOVA, LSD post hoc 







6.1.4 Unpublished data (B): Detection of Collagen Type I in Collected 
Cultivation Media after Cultivation with Ultra-Fine Grain Titanium 
In the final assessment of the biological responses to UFG-Ti we returned to 
the cultivation of cells. We obtained the fundamental knowledge about the initial 
phase of interactions of UFG-Ti in the biological environment. The aim of this work 
was to determinate the fate of cells adhered to the UFG-Ti in a longer time period. 
As osteoblasts showed the best results from all tested cell types on the material, the 
SAOS-2 cell line was used for the experimental purposes again. The sign of 
osteoblasts good prosperity and terminal osteocyte differentiation is the production 
of collagen type I. Quantification of the produced amount of collagen type I by 
SAOS-2 cells was performed at four selected time points during 14 days of 
cultivation. 
SAOS-2 cells were seeded and cultivated the same way and under the same 
condition as it is described in Publication A. Nevertheless, this time, every 5th, 8th, 
12th and last 14th day of cultivation the medium from each UFG-Ti sample was 
collected and frozen until the day of assessment.  
The results showed that at every time point the production of collagen type I 
was higher on UFG-Ti samples than on PS control (Fig. B9). Production of collagen 
type I increased with the time for 12 days. After this time point, the production starts 
to decrease, yet the same trend was observed also on PS control. Sum amount of 
collagen type I produced during the 14 days of cultivation suggests no relevant 
differences among UFG-Ti samples, though statistical analysis was not performed 
due to the lack of data (Fig. B10).  
Described work was devoted to the evaluation of long-time condition of 
osteoblasts on UFG-Ti. From the obtained data it could be deduced that UFG-Ti 
samples stimulate osteoblasts to produce high quantity of collagen type I; thus UFG-
Ti samples still prove their application potential for bone or dental implant 
development. It should be mentioned, that this work touches the topic only 





Figure B9: Measured production of collagen type I by osteoblasts (SAOS-2) 







Figure B10: Sum collagen type I production by osteoblasts (SAOS-2) cultivated 








6.2 PART II: Silicon-based Nanoparticles – Cytotoxicity and Basic 
Imaging (C-E) 
Part II of the thesis describes elemental reactions of different human cell types 
to fluorescence silicon-based nanoparticles. Silicon nanoparticles emerge the 
immense interest in nanomedicine based on their unique chemical-physical 
properties and entail the rapid progress of this field. Silicon biodegradability 
predicted the possible use of silicon-based nanoparticles in biomedicine especially 
for development of the brand-new therapeutic and imaging techniques. Currently, the 
ultra-small nanoparticles which were used in this study (diameter ≤ 4 nm) still lack 
sufficient biological scientific background since there are only several conflicting 
publications. Cytotoxicity assessment is of the greatest concern as this makes up the 
most important initial step for any further biological application. Moreover, for better 
understanding of the causes of the cytotoxicity there is a need of description of 
specific cell–nanoparticle interactions on the elemental level. 
Publication C aims to the determination of the appropriate concentration of two 
types of silicon-boron quantum dots (SiQDs) based on the influence on metabolic 
activity of human osteoblasts cell line (SAOS-2). Obtained results were put into 
correlation with the cellular uptake of both SiQDs evaluated by means of 
fluorescence wide-field and confocal microscopy. Above that, presence or absence of 
fetal bovine serum (FBS) in the cultivation media was selected as the main variable 
in all experiments and its influence on basal cell-SiQDs interactions was discussed. 
Publication D enlarges the findings of cytotoxicity of one of the SiQDs from 
publication C. Human monocytic cell line (THP-1), primary hMSCs and SAOS-2 
cells were employed to the similar cytotoxicity experiments based on the knowledge 
from publication C. Moreover, determination of necrosis was added to the 
evaluation. Different types of silicon nanoparticles – silicon-carbide (SiCs) were 
tested in unpublished data (E) with the same experimental set-up as used in the 
previous work with SiQDs.  
The extensive cooperation of different scientific fields was employed in this 
research. The author of the thesis performed the biological part of the work 
(publication C and unpublished data E) and in publication D figured as a mental 
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assistance for the experiments. Further work was done by colleagues from 
Department of Electrical and Electronic Engineering, Graduate School of 
Engineering, Kobe, Japan and Wigner Research Centre for Physics, Budapest, 
Hungary (fabrication and optical characterization of SiQDs and SiCs, respectively) 
and from Faculty of Mathematics and Physics, Prague, Czech Republic (advanced 
optical characterization and zeta potential measurement). 
 
 
6.2.1 Publication C: The impact of doped silicon quantum dots on human 
osteoblasts 
Lucie Ostrovská, Antonín Brož, Anna Fučíková, Tereza Bělinová, Hiroshi 
Sugimoto, Takashi Kanno, Minoru Fujii, Jan Valenta, Marie Hubálek Kalbáčová 
(2016): The impact of doped silicon quantum dots on human osteoblasts. RSC 
ADVANCES 6, 63403-63413. IF = 2.936 
Up to the present, the main application spectrum of SiQDs was found in the 
field of optics and electronics, yet their unique properties revealed its significant 
potential for the use in biology and medicine. Biocompatibility and natural 
biodegradability of SiQDs inspired the idea of the expansion into the field of 
biology. In addition, natural photoluminescence with high quantum yields and low 
photobleaching coefficients present rare prerequisites for imaging, bio-sensing or 
drug delivery without any further redundant intervention into their structure. 
Nevertheless, biocompatibility of any newly synthesized silicon-based nanoparticles 
must be confirmed together with the determination of the highest possible non-toxic 
concentration. For future bio-medical application, it is also inevitable to understand 
the interactions of SiQDs in biological environment. 
In this first paper, two chemically identical SiQDs with different size and peak 
emission were tested for cytotoxicity at various concentrations (25, 50 and 125 µg 
ml
-1
) at different time points (6, 24 and 48 hours) on SAOS-2 cells in the presence or 
absence of FBS in the cultivation medium (+/- FBS). Mentioned types of SiQDs 
were synthesized using different annealing temperatures which implies its 
designation - 1100 (4 nm size, 850 nm peak emission) and 1050 (3 nm size, 750 nm 
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peak emission).  Detailed characterization of SiQDs is described in publication C 
(Fig. 1, 2, 3, 4). At 2, 6 and 24 hours cellular uptake of both SiQDs (50 µg ml
-
1) in 
+/- FBS cultivation media was evaluated using fluorescence wide-field and confocal 
microscopy.  
At the 6 hour time-point, SiQD 1100 in the + FBS medium did not 
significantly influenced metabolic activity of SAOS-2 cells irrespective of 
concentration (Fig. 5a in publication C). On the other hand, SiQD 1050 (the lowest 
and middle concentration) increased cell metabolic activity and the same trend was 
observed even after 24 hours of incubation, yet the increase was not significant. 
SiQD 1100 decreased the metabolic activity after 24 hours at the highest 
concentration and after 48 hours the decrease was measured also for the middle 
concentration.  Also SiQD 1050 decreased metabolic activity after 48 hours but only 
at the highest concentration (Fig. 5b in publication C). In the – FBS medium, SiQD 
1100 affected metabolic activity only at highest concentration after 6 hours while 
SiQD 1050 did not affected cell behavior at any concentration. After 24 hours also 
middle concentration of SiQD 1100 strongly decreased cell metabolic activity while 
more dramatic situation appeared with SiQD 1050 where all tested concentration 
decreased metabolic activity to cytotoxic level. Eventually, both SiQDs exhibited 
cytotoxic effect at all concentration after 48 hours in – FBS medium (Fig. 5c,d in 
publication C). 
Visual inspection of SiQD 1100 in + FBS medium showed that the first signal 
could not be detected until 24 hours inside the cells. Until that time, all detected 
signal originated from the clusters formed outside the cell (Fig. 6a,c in publication 
C).  Importantly, no morphological alterations were observed after the incorporation 
of SiQDs 1100 after 24 hours. In the case of SiQDs 1050, very strong fluorescence 
signal was detected from the very start of microscopy observation, yet it was 
apparent that the signal originated from huge foggy aggregates covering the cells 
from the outside. This finding was confirmed by confocal imaging after 24 hours 
where only a very weak signal was detected inside the cells while most of the SiQDs 
1050 were found in culture medium (Fig. 6b,d in publication C). SiQD 1100 in – 
FBS medium were detected inside the cells from the beginning (2 hours) and their 
concentration increased over time causing the changes in morphology after 24 hours 
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(Fig. 7a,c in publication C). Moreover, form of the signal inside the cells was 
diffused while in + FBS medium, the signal was detected in vesicular structures. 
SiQD 1050 in – FBS media was not possible to detect at any time point inside the 
cells but significant structural changes in cell morphology were observed after 24 
hours (Fig. 7b,d in publication C). 
This publication tested two types of SiQDs in biological environment for the 
very first time. Cytotoxicity assessment provided information about the toxic 
concentrations and microscopy imaging revealed the processes standing behind the 
measured cytotoxicity. All further work with silicon-based nanoparticles followed 
the experimental set-up from this publication.  
 
 
6.2.2 Publication D: Silicon Quantum Dots and Their Impact on Different 
Human Cells 
Tereza Bělinová, Lucie Vrabcová, Iva Machová, Anna Fučíková, Jan Valenta, 
Hiroshi Sugimoto, Minoru Fujii, Marie Hubálek Kalbáčová (2018): Silicon Quantum 
Dots and Their Impact on Different Human Cells. Phys. Status Solidi B, 255, 
1700597. IF = 1.729 
Based on the results from publication C, following study aimed to the testing of 
SiQDs on different cell types. From the two tested SiQDs, only one (SiQD 1100) 
was selected for further detailed research as it demonstrated better results for 
possible bio-applications. Prospective utilization of SiQDs in human medicine 
influenced the selection of tested cell types. Immune cells will be the first cells to 
encounter SiQDs after their application into organism; thus, monocytic cell line 
(THP-1) was chosen in a first place. hMSCs were chosen as the representative 
primary cells to compare their results with the results obtained from the cell lines. 
Finally, SAOS-2 cells were used again as already well-established cell line in 
interactions with SiQDs. Evaluation of metabolic activity was this time accompanied 
with the cell death (necrosis) detection. Presence of FBS stayed as an important 
variable in all experiments. 
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All three cell types were employed in evaluation of cytotoxicity with SiQDs 
concentrations of 25, 50 and 100 µg ml
-1
. Time-points of 6, 24 and 48 hours were 
used for SAOS-2 cells and 6 and 24 hours for the rest of the cell types. THP-1 cells 
were used in two stages – suspension monocytes and adherent macrophages. 
Determination of necrosis (lactate dehydrogenase LDH) was carried out with SAOS-
2 cells and hMSCs after 6, 24, 48 hours and 6, 24 hours, respectively. The same 
concentrations of SiQDs as in cytotoxicity experiments were employed. 
Metabolic activity of SAOS-2 cells in +FBS medium decreased with the time 
only at the highest concentration of SiQDs where the cytotoxic level was attained 
already after 6 hours. In –FBS medium, the level of cytotoxicity was reached after 48 
hours also in the middle concentration of SiQDs (Fig. 2a,b in publication D). hMSCs 
decreased significantly their metabolic activity after 24 hours in almost all 
concentrations of SiQD both in + an – FBS medium. None of the values decreased to 
the cytotoxic level though (Fig. 2c,d in publication D). Monocytes THP-1 in + FBS 
medium showed increase of the metabolic activity in the first 6 hours in all 
concentrations of SiQDs and at 24 hours no differences with the control were 
detected. In – FBS medium the initial increase was not observed and at 24 hours the 
level of cytotoxicity was attained in the middle and the highest concentration of 
SiQDs (Fig. 2e,f in publication D). Macrophages THP-1 in + FBS medium showed 
the 6 hours increase of metabolic activity only in the highest concentration of  
SiQDs, while after 24 hours the highest concentration evinced the lowest values. In – 
FBS medium the situation was comparable to monocytes, yet the decrease was more 
dramatic in all concentrations of SiQDs (Fig. 2g,h in publication D). 
Significantly higher LDH concentrations compared to negative control were 
detected from SAOS-2 cells in + FBS medium in the highest concentration of SiQDs 
after 48 hours. In – FBS medium this situation occurred already after 24 hours (Fig. 
3a,b in publication D). hMSCs on the other hand exhibited only negligible amount of 
LDH, irrespective to concentration of SiQDs or presence of FBS (Fig. 3c,d in 
publication D). 
 
This publication extended our knowledge about the cytotoxicity of SiQDs to 
primary hMSCs and immune cell line THP-1. Additionally, the possible way of 
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6.2.3 Unpublished data (E): Evaluation of Cytotoxicity of Silicon-Carbide 
Nanoparticles 
Previous studies in publications C and D performed with SiQDs motivated the 
need of the comparison with some other type of silicon-based nanoparticles. Well-
established methodology of nanoparticle cytotoxicity evaluation on SAOS-2 cells 
enabled the employment of different silicon nanoparticles doped with carbide atoms 
(SiCs) without protracted initial verification of the experimental set-up. Tested SiCs 
exhibited even smaller average diameter than previously used SiQDs – only 2nm. 
Among their properties similar to SiQDs, the long-time stability in water was their 
main benefit. Unfortunately, their peak emission was determined in 450 nm, which 
ruled out the possibility of correct visualization as this value totally overlaps with the 
cell autofluorescence.  
Cytotoxic evaluation was carried out in very similar manner as it was described 
in both publications C and D. Time-points of the assessment were set at 24 and 48 
hours with the concentrations 50, 100 and 250 µg ml
-1
 of SiCs. Experiments were 
performed with SAOS-2 cells in presence or absence of FBS. 
Cell metabolic activity in + FBS media at 24 hours was significantly decreased 
in middle and the highest concentration of SiCs, the highest concentration even 
reached the cytotoxicity level - 25% reduction of metabolic activity (Fig. E1). 
Surprisingly, after 48 hours metabolic activity increased in all concentrations of 
SiCs, yet the highest concentration was still considered cytotoxic. The similar 
situation after 24 hours was observed also in –FBS medium. Furthermore, although 
after 48 hours metabolic activity also increased, all SiCs concentrations reached the 
level of cytotoxicity. Surprisingly, the negative influence of FBS absence was not 
apparent until 48 hour time-point.  
This research was inspired by previous publications with SiQDs. Acquired 
results showed that even though all silicon-based nanoparticles are considered 
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biocompatible and non-cytotoxic, there is always a need of detailed study of 
cytotoxicity to set conditions in which this type of nanomaterial really fulfill its 




Figure E1: Metabolic activity of osteoblasts (SAOS-2) cultivated with different 
concentrations of SiCs in presence or absence of FBS after 24 and 48 hours. 
Relative values are expressed as a percentage of + FBS control at 24 hours (dashed 
line). Asterisk (*) means a significant difference from appropriate time and +/- FBS 
control (Wilcoxon matched-pairs test, p ˂ 0.05). Groups marked with different black 
upper-case letters (24 h), black lower-case letters (48 h), red upper-case letters (+ 
FBS) or red lower-case letters (- FBS) express significant inter-group difference 
within variables (ANOVA, LSD post hoc test, p ˂ 0.05).  
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6.3 PART III: Silicon Quantum Dots – Advanced Visualization (F) 
Part III of the thesis is devoted to the work made on advanced microscopic 
imaging of SiQDs in cell culture. In publication C we described the way of SiQDs 
visualization by the means of fluorescence wide-field and confocal microscopy. Final 
results of imaging were preceded by the long and challenging process to set up the 
correct technical adjustment. The most demanding tasks were to acquire sufficient 
strong signal from SiQDs as the emission peak lies in near-infra red part of the light 
spectrum and to distinguish the SiQDs signal from inner cell autofluorescence. Final 
setting enabled further detailed imaging of the SiQDs entry and movement inside the 
cells. The way of entry and subsequent movement of such small nanoparticles is not 
easy to detect. Tracking SiQDs in time inside the cells is a very extensive subject of 
research and this study strived to optimize the visualization techniques to obtain 
reliable and replicable results. 
The first section of Part III relates to the detection of SiQDs signal inside the 
SAOS-2 cells at different time-points and its spatial correlation with the fluorescently 
stained endocytic structures, specifically, late endosomes and lysosomes. 
Colocalization analysis of these two fluorescent signals was carried out on 2D and 
3D projections. Experiments were performed in the presence or absence of FBS.  The 
second section summarizes the work on live imaging of SAOS-2 cells in time after 
the addition of SiQDs. Fluorescent signal of SiQDs together with bright-field 
imaging of cell morphology was tracked until the cell death. 
The first section was entirely performed by the author of this thesis while the 
second section was performed under supervision of colleague from the Institute of 





6.3.1 Unpublished data (F): Colocalization of Selected Endocytic Cell Structures 
with Silicon Quantum Dots 
First image analysis in publication C indicated that specific conditions must be 
met for SiQDs to enter the cell in detectable amount.  Based on visualization 
conclusions from publication C, only SiQD 1100 were selected for following 
detailed study of their internalization in SAOS-2 cells. Furthermore, the presence or 
absence of FBS in cultivation media after the addition of SiQDs to the cells seemed 
to have a deep impact on the final amount of SiQDs inside the cell and the type of 
the detected signal herein (vesicle-like or diffuse form). In this study we aimed to 
prove whether cells use endocytosis in order to internalize and further process 
SiQDs. Signal from two endocytic structures (late endosomes and lysosomes) was 
colocalized in time with the signal from SiQDs by software analysis and their final 
interrelation was expressed by Pearson‘s correlation coefficient and Manders split 
coefficient. Pearson‘s correlation coefficient expresses the result as +1 for perfect 
correlation, 0 for no correlation, and -1 for perfect anti-correlation. Manders split 
coefficient is proportional to the amount of fluorescence of the colocalizing pixels or 
voxels in each color channel. An image with an overlap coefficient equal to 0.5 
implies that 50% of both components of the image overlap with the other part of the 
image. If the number of objects is not equal or similar then determination of two co-
localization coefficients M1 and M2 is the proper method. 
Statistical expression of colocalization by mentioned coefficients was also 
compared with each other and their suitability for our estimations was discussed. 
Moreover, fluorescent images were acquired in 2D and 3D projections and their 
mutual correspondence of colocalization results was compared. 
SAOS-2 cells were cultivated with the concentration of 200 µg ml
-1
 of SiQDs 
in the presence of FBS in cultivation media. Endocytic structures – late endosomes 
and lysosomes were immunofluorescently stained with appropriate antibodies 
(M6PR and LAMP2, respectively) at 1, 4 and 24 hours. 2D and 3D images of two-




The signal of SiQDs was mostly detected on the outside of the cell membrane. 
Nevertheless, in the case of FBS presence, the signal was more intense suggesting 
the clustering of SiQDs (Fig. F1). The 3D spatial placement of SiQDs inside the cells 
also confirmed localized vesicle-like signal (Fig. F2). The SiQDs signal in FBS 
absence was hard to detect inside the cells and was usually diffuse (Fig. F3). This 
finding led to elimination of FBS-free cultivation conditions from the overall 
colocalization analysis due to irrelevant results. Both findings about the influence of 
FBS presence or absence on SiQDs‘ signal type and placement correspond to the 





   
   
Figure F1: Representative images of osteoblasts (SAOS-2) cultivated with SiQDs 
in the presence of FBS after 24 hours. After cultivation, SAOS-2 cells were stained 
for visualization of late endosomes (a-c) and lysozomes (d-f). (a,d) acquired SiQDs 
signal (700-775 nm), (b) late endosomes stained by indirect immunofluorescent 
staining - M6PR + secondary antibody conjugated with AF568 (609-654 nm), (e) 
lysozomes stained by indirect immunofluorescent staining – LAMP2 + secondary 
antibody conjugated with AF568 (609-654 nm), (c,f) merge of the two fluorescent 
channels with bright-field Nomarski contrast (artificial colorization: red – SiQDs, 
green – endocytic structures, yellow – overlap indicating colocalization). 
  
(a) (b) (c) 
(d) (e) (f) 
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Figure F2: Representative 3D images of osteoblasts (SAOS-2) cultivated with 
SiQDs in the presence of FBS after 24 hours. Merge images of two fluorescent 
channels with artificial colors - late endosomes (green) and SiQDs signal (red) (a) or 
lysozomes (green) and SiQDs signal (red) (b). Yellow color indicates colocalization 
of both channels.  
 
   
   
Figure F3: Representative images of osteoblasts (SAOS-2) cultivated with SiQDs 
in the absence of FBS after 24 hours. After cultivation, SAOS-2 cells were stained 
for visualization of late endosomes (a-c) and lysozomes (d-f). (a,d) acquired SiQDs 
signal (700-775 nm), (b) late endosomes stained by indirect immunofluorescent 
staining - M6PR + secondary antibody conjugated with AF568 (609-654 nm), (e) 
lysozomes stained by indirect immunofluorescent staining – LAMP2 + secondary 
antibody conjugated with AF568 (609-654 nm), (c,f) merge of the two fluorescent 
channels with bright-field Nomarski contrast (artificial colorization: red – SiQDs, 
green – endocytic structures, yellow – overlap indicating colocalization). 
(a) (b) 
(a) (b) (c) 
(d) (e) (f) 
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Unsuitability of Pearson‗s correlation coefficient for our estimations was 
evident already during image analysis. As it turned out, this coefficient is very 
sensitive to irregular noise in images. Moreover, no colocalization (value lower than 
0.5) of endocytic structures and SiQDs signal was not detected at any time point 
(Fig. F4). However, comparison of 2D and 3D projection for colocalization analysis 
showed very similar results. On the other hand, interpretation of two-channel overlap 
by Manders split coefficients was much easier. It consists of two coefficients - M1 
and M2 to show how much certain channel overlaps the other (%). M1 coefficients 
are shown in graphs and indicate the portion of overlapping SiQDs signal with 
endocytic structures. M2 coefficients indicate the portion of overlapping endocytic 
structures with SiQDs signal which did not interpret principally the colocalization of 
SiQDs, thus they are not presented in graphs. The highest portion of colocalization 
(over 70%) of SiQDs was detected at 1 hour with M6PR (Fig. F5). More differences 
were observed between 2D and 3D projection analysis. Colocalization of SiQDs with 
M6PR implies that the amount of SiQDs in M6PR decreases in time. In the case of 
LAMP2, the situation with colocalization with SiQDs is not so unambiguous.  
This research provided rough information about the way of SiQDs entry into 
the cells, yet endocytosis was not certainly confirmed. Manders split coefficient was 
approved as more suitable for interpretation of colocalization than Pearson‘s 
coefficient. However, in this case, only more detailed 3D images should be used for 
evaluations, as with Manders split coefficient there were detected differences 









   
Figure F4: Pearson’s correlation coefficient values showing colocalization of 
SiQDs with late endosomes and lysozomes in the presence of FBS after 1, 4 and 




   
Figure F5: Manders M1 split coefficient values showing proportional overlap of 
SiQDs with late endosomes and lysozomes in presence of FBS after 1, 4 and 24 









6.3.2 Unpublished data (F): Live Imaging of Cells Interacting with Silicon 
Quantum Dots 
Visualization of SiQDs in cell cultures in time was actually the first imaging 
experiment of SiQDs; thus, this study preceded all previous experiments. The 
principal task of these experiments was to estimate the time-points of first SiQDs 
entry into the cells, the loss of SiQDs signal due the processing in cell or the cell 
death. This information would therefore lead the experimental set-up of following 
visualization studies. Live tracking of SiQDs on their way from the cultivation 
medium through the cell membrane and their subsequent accumulation inside the cell 
would give us important connection with the measured time-dependent SiQDs 
cytotoxicity. In order to ensure stable and convenient environment for cells during 
imaging, only standard cultivation method (15% FBS supplemented medium) was 
employed. 
After the addition of 100 µg ml
-1 
SiQDs to SAOS-2, cells were transferred into 
the preheated chamber on the table top of Nikon microscope. Images were acquired 
approximately every 30 minutes until the cell death. Maximum overall time-lapse of 
the experiment was 24 hours, however, only first 180 min are presented in this thesis 
(Fig. F6)  
All experiments showed large similarity in time-lapse cell viability. The first 
images were taken after 30 minutes from the SiQDs addition to the SAOS-2 cells 
(Fig. F6). Inside the selected cells, there were already plenty of small vesicles 
emitting SiQDs signal. Amount of the SiQDs signal  increased in time, but after 90 
minutes from the addition, cells started to shrink and the SiQDs signal faded away. 
After 150 minutes, observed selected cells detached from the surface and in next 30 
minutes were dead. SiQDs signal vanished together with the cells. However, even 
cells with less or no SiQDs signal died in the same manner. Moreover, the cells 
tracked after the 180 min time-point died even faster which suggested that the main 
reason for cell death was the long-time exposure to the extensive UV irradiation. In 
all experiments cells started to die quickly after the acquisition of the first image. 
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This study quit the live imaging experiments due to excessive cell death after 
immense UV irradiation needed for SiQDs excitation. Thus, all further experiments 
were performed on fixed cells. 
   
   
   
   
Figure F6: Time-lapse images of osteoblasts (SAOS-2) from 30 to 180 minutes 
after SiQDs addition to cultivation medium. (a-f) fluorescent images of SiQDs 
signal, (g-l) merged images of fluorescent SiQDs channel and bright-field Nomarski 
contrast (SiQDs in red). 
(a) (b) (c) 
(d) (e) (f) 
(g) (h) (i) 
(j) (k) (l) 
30 min 60 min 90 min 
120 min 150 min 180 min 
30 min 60 min 90 min 
120 min 150 min 180 min 
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6.4 PART IV: Gold and Platinum Nanoparticles (G) 
 
6.4.1 Publication G: Preparation of Noble Nanoparticles by Sputtering – Their 
Characterization 
 
Markéta Pišlová, Marie Hubálek Kalbáčová, Lucie Vrabcová, P. Slepička, Zdeňka 
Kolská, V. Švorčík (2018): Preparation of Noble Nanoparticles by Sputtering – Their 
Characterization. Digest Journal of Nanomaterials And Biostructures 13, 1035-1044. 
IF = 0.673 
Besides silicon-based nanoparticles, also metal nanoparticles were tested for 
their cytotoxicity in accordance with the established protocols from PART II. Unlike 
silicon-based nanoparticles, gold (AuNPs) and platinum (PtNPs) nanoparticles are 
not biodegradable and they do not emit the natural photoluminescence. However, the 
main potential of these nanoparticles in human medicine lies in the antitumor and 
antibacterial activity (AuNPs) or antioxidant activity and phototermal treatment 
(PtNPs). Several approaches are used to prepare metal-based nanoparticles, yet only 
the physical methods do not pose a risk for utilization in biomedicine. AuNPs and 
PtNPs tested in this publication were prepared by direct sputtering into liquid 
medium of polyethylene glycol (PEG). By this method, stable nanoparticles of 
unified shape and size were fabricated.  
This research is based on the cooperation of biological and chemical sectors. 
The biological part was performed by the author of the thesis while preparation and 
characterization of the nanoparticles was done by colleagues from Department of 
Solid State Engineering, University of Chemistry and Technology, Prague and from 
Faculty of Science, J. E. Purkyně University, Ústí nad Labem. 
Cytotoxity of spherical AuNPs (diameter of 6.3 nm) and rod PtNPs (1.5 x 4.2 
and 1.5x7.9 nm) (Fig. 4 in publication G) was evaluated on cell culture of SAOS-2 
cells in standard cultivation medium after 24 hours. Gradually increasing 
concentrations of both nanoparticles were used for testing of their influence on cell 
metabolic activity – 0.56, 2.8, 5.6, 8.4, 11.2 and 14 mg L
-1
 of AuNPs and 0.6, 3, 6, 9, 
12 and 15 mg L
-1
 of PtNPs.  
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Despite the similar concentrations of AuNPs and PtNPs, more cytotoxic effect 
was observed in case of SAOS-2 cells treated with AuNPs (Fig. 6 in publication G). 
No significant decrease in metabolic activity in comparison to untreated cells was 
detected for the two lowest concentrations of AuNPs while in the case of PtNPs no 
significant decrease was observed for the three lowest concentrations. Cytotoxic 
effect was observed in cells treated with AuNPs of 11.2 mg L
-1
, whereas the same 
effect was observed with PtNPs only after using 15 mg L
-1
 (Fig. 6 in publication G). 
Representative images of the influence of the lowest and highest concentrations of 
both nanoparticles on SAOS-2 cells viability are illustrated in Fig. 7 in publication G. 
In this publication we estimated the cytotoxic concentrations of AuNPs and 
PtNPs under the standard cell cultivation conditions. This fundamental study was 
extended by additional experiments with AuNPs with different PEG termination and 


















This thesis is based on the study of two types of nanomaterials with the 
intended use in biomedicine. First part is dedicated to ultra-fine grain titanium as a 
surface nanomaterial and other three parts focus on nanoparticles of different origin. 
 
Standard (S) and two novel UFG-Ti materials (Z and M) with improved 
mechanical properties for prospective development of various medical implants are 
described in Part I of the thesis (publication A, unpublished data B). Commercially 
pure titanium is long-time distinguished for its exceptional biocompatibility, yet the 
new manufacturing technique must prove its suitability for fabrication of the titanium 
material with the same or even improved characteristics for utilization in 
biomedicine. Moreover, from the perspective of cell biology, the surface treatment is 
of capital importance due to the significant influence on the adhesion, growth, and 
morphology of cultivated cells (Naddeo et al., 2015; Ren et al., 2018). Evaluation of 
these initial short-term interactions of cells with UFG-Ti samples was performed in a 
first place to determine whether this material initiates proper cell adhesion in 
sufficient amount of cells which would be followed by adequate proliferation and 
possibly differentiation to form final tissue.  
First, bone-related cells – human osteoblasts and mesenchymal stem cells were 
selected for the testing of cytocompatiblity as they will prospectively commonly 
interact with UFG-Ti in a form of dental or orthopedic implant. Osteoblasts, 
represented by cell line SAOS-2, showed comparable or better results on all UFG-Ti 
samples than PS control. The initial attachment (2 hours) of SAOS-2 cells on UFG-
Ti was increased, yet the further growth (48 hours) was slightly slowed down 
compared to PS control, which indicates that the cells tried to adapt to the uneven 
surface. This statement corresponds to the results of metabolic activity after 48 
hours, where higher cell number on UFG-Ti samples did not cause increase in 
metabolic activity possibly because of the adaptation process. The same situation 
was observed also with primary hMSCs, yet the increase of initial adhesion was not 
as much dramatic as with SAOS-2 cells. Consequently, the slower growth led to 
lower cell number on all UFG-Ti samples than on PS control which together with 
metabolic activity results suggest noticeable demands of UFG-Ti surface on hMSCs 
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adaptation. This finding is consistent with several cytocompatibility studies of 
different titanium materials (Kubo et al., 2009; Medvedev et al., 2017; Richert et al., 
2008). Unfortunately, despite very similar experimental set-up, most of the current 
studies focus mainly on the comparison of influence of different surface topographies 
among the titanium samples without correlation to standard cultivation material 
(polystyrene) (Gui et al., 2018; Kang et al., 2018; Ren et al., 2018). Lack of this 
information, though, cannot reliably report, whether such material induces sufficient 
proliferation as standard cultivation material is specially designed to promote cell 
adhesion and growth. Furthermore, both cell types displayed significantly smaller 
size on all UFG-Ti samples than on PS control after 48 hours. Zinger et al. 
hypothesized, that this phenomena is caused by integrating the cell mass deep into 
the surface structures resulting in smaller yet thicker cells, however, cell thickness 
was not estimated in our study (Zinger et al., 2004).  
Later assessment with SAOS-2 cells only, was focused on production of 
collagen type I during long-time cultivation (14 days) on UFG-Ti samples. In the 
course of cultivation, higher production of collagen type I was detected on all UFG-
Ti samples than on PS control. This may be caused either by higher number of 
SAOS-2 cells on UFG-Ti samples, which was determined at 48 hours, or by 
stimulation to differentiation by rugged surface. Influence of surface topography of 
titanium on osteoblasts collagen type I production was studied with inconsistent 
results from no effect to significant increase of production by several research groups 
(Iwaya et al., 2008; Mariscal-Muñoz et al., 2016; Zhao et al., 2010).  
Until this point, no significant influence of the type of surface treatment 
(polishing vs. grinding) on cells was detected. Finally, differences were revealed in 
morphology and focal adhesions observations after 48 hours of cultivation. 
Although, SAOS-2 cells cultured on both UFG-Ti samples displayed the same shape 
as on PS control, their focal adhesions on ground samples were usually placed on the 
cells extensions while on polished samples most of the focal adhesions were find in 
the basal pole of the cells. The surface of polished samples comprised of 
predominantly continuous nanotopography, thus the cell anchoring to the surface 
took place on the whole bottom pole of the cell. In contrary, ground samples as a 
combination of micro/nano topography with numerous peaks and valleys force the 
cells to adhere onto the elevated structures and form ―bridges‖ among these 
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structures in order to anchor the whole cell (Lagonegro et al., 2018). hMSCs 
cultivated on polished surfaces displayed variable shapes and diverse orientation of 
growth as they were not limited by fluctuating topography features. Moreover, more 
solitary cells were found on this type of surface. Ground samples more or less 
directed the cells growth along the valleys and around higher peaks which resulted in 
formation of cells elongated in variable directions and connected tightly one to 
another. This finding is consistent with many other studies (Babuska et al., 2018; 
Chen et al., 2012; Teng et al., 2012), where mostly micro/nano topography is 
confirmed as a suitable surface for future hard tissue implants as it resembles natural 
bone structure (Mulari et al., 2004).  
Although both mentioned cell types resemble with their interactions to UFG-Ti 
samples, the apparent difference in cell morphology and spreading led to the 
employment of another primary cell type and immortalized cell line for evaluation of 
cell responses to UFG-Ti. Therefore, further assessment was performed on primary 
human dermal fibroblasts and keratinocyte cell line HaCaT, which both represent the 
soft tissue as a contrast to osteoblasts representing hard tissue. Integrity of soft-
tissue-implant interface is crucial for the proper function of special types of titanium 
implants. Such bone-anchored transcutaneous implants overcome problems of 
conventional amputation prostheses (pain, necrosis) by direct contact to the skeleton 
through the support of soft tissue (Chen et al., 2009). 
As it was expected, NHDF exhibited very similar results to hMSCs in all 
observed characteristics (cell proliferation, cell area, cell morphology and metabolic 
activity), confirming the statement, that primary cells interactions with an artificial 
material are specific and more sensitive (Markhoff et al., 2017). Yet it should be 
noted, that principally the cell area assessments were highly influenced by the state 
of the donor at the time of the cells isolation. On the other hand, HaCaT displayed 
ambiguous results. Their initial attachment was higher on UFG-Ti samples than on 
PS control yet their further proliferation rate was not assessed. Metabolic activity 
was decreased insignificantly and cell area was comparable to the cells on PS 
control. However, the way of growth was affected by surface treatment resulting in 
forming incoherent layers of a small number of cells on ground samples which 
assume further problems with integrity of the whole tissue. The same findings were 
described by several studies where cells derived from soft-tissue preferred simple 
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nanostructured topography to the more roughed surface (Pendegrass et al., 2008; Tan 
et al., 2017). 
Besides the biocompatibility, the biological lifespan of an implant is defined 
also by its low immunogenicity. Detection of inflammatory cytokines IL-8 and TNF-
α in blood samples during 6 hours cultivation revealed increased values of both 
cytokines compared to PS control. Moreover, significantly higher amount was 
detected on ground samples, which in case of TNF-α is apparent only in the 
comparison of individual donors. Increased levels of cytokines caused by the 
presence of titanium material with micro/nano topography was observed in many 
studies (Markhoff et al., 2017; Östberg et al., 2015). Importantly, the profound 
inflammatory response (comparison with LPS control) was not attained by any of the 
UFG-Ti sample. The research of Lamers et al. rationalized the increased values of 
inflammatory cytokines on textured surface by macrophage activation to induce a 
wound healing rather than inflammatory response (Lamers et al., 2012).  
In summary, all tested UGF-Ti samples with both surface modifications were 
stated as biocompatible with all tested cell types. Yet the best results were obtained 
for osteoblasts-like cells, which is a favorable outcome in the perspective of 
orthopedic or dental implant development. 
 
Part II of the thesis (publications C and D, unpublished data E) focuses on the 
assessment of cytotoxicity of silicon-based nanoparticles to various cell types under 
different cultivation conditions accompanied with microscopic visualization of their 
presence inside the cells. Last decade, the main challenge in development of silicon 
nanoparticles for bioimaging was their stability in polar solvents (aqueous biological 
fluids) while maintaining the unique photoluminescence. Several approaches were 
proposed to prevent undesired agglomeration and alteration of optical characteristics 
e.g. micelle encapsulation (Erogbogbo et al., 2008) or stabilization by organic 
ligands (Hessel et al., 2012), but other difficulties (impossible functionalization, high 
sensitivity of luminescence to organic ligand) emerged. Preserving the inorganic 
nature of silicon nanoparticles to retain high photoluminescence quantum yield 
became an important task for their potential utilization in biology and biomedicine. 
Initially, all-inorganic silicon quantum dots co-doped with boron and 
phosphorus were studied with respect to their impact on different human cells. The 
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unique technique of preparation is based on formation of the core which is protected 
by heavily doped shell; thus photoluminescence of the core is less sensitive to the 
environment. Moreover, negative surface of the shell ensures the long-time SiQDs 
stability in water (Fujii et al., 2016). Due to their high stability, emission peak in 
near-infra red ranges and environment-friendly character, the possible use in bio-
imaging was proposed. Since the evaluation of cytotoxicity was the very first time, 
when this type of SiQDs was introduced to the biological environment, this study 
practically represents a basic research. At first, SiQD 1100 (size of 4 nm) and 1050 
(size of 3 nm) were selected for the testing and despite their identical chemical 
nature, significant differences arose in biological environment of the SAOS-2 cell 
culture. Particularly, the presence of FBS proteins, which causes the protein corona 
formation, radically affected behavior of both SiQDs types. The formation and 
structure of the protein corona (PC) is crucial for the fate of nanoparticles in 
biological fluids since PC influences nanoparticle uptake and the way of entry into 
the cells (Catalano et al., 2015; Ho et al., 2018; Long et al., 2018). The presence of 
FBS caused cytotoxicity effect of SiQD 1100 only at the highest (125 µg ml
-1
) 
concentration after 24 hours while for SiQD 1050 such effect was detected only after 
48 hours. However, possible positive conclusion for SiQD 1050 was denied by 
subsequent microscopic inspection, where extensive amount of protein/SiQD 1050 
agglomerates covering the cells from the outside was detected. Only negligible 
amount of SiQD 1050 was observed in 3D inside the cells, thus we hypothesized that 
most of SiQD 1050 were attached in agglomerates and were not available for cellular 
uptake. Aggregation of some types of nanoparticles in biological fluids remains 
unexplained, yet this effect was reported in many studies (Calatayud et al., 2014; 
Hemelaar et al., 2017). On the other hand, SiQD 1100 were detected inside the cells 
in the presence of FBS after 24 hours in a form of vesicles which suggested their 
potential uptake by endocytosis. Furthermore, both SiQDs harmed the SAOS-2 cells 
earlier and at a lower concentration in the absence of FBS. In the case of SiQD 1050 
the cytotoxic effect was determined already after 24 hours at all concentrations. 
Fluorescence microscopy partly clarified this finding when different signal 
distribution inside the cells was detected for SiQD 1100. Observed diffuse signal in 
the cytoplasm indicated that SiQD 1100 enter the cells by different routes in 
dependence on the presence or absence of FBS. In contrary, despite their cytotoxic 
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effect, SiQD 1050 were not detected in the cells. These contradictory results may be 
explained by substantially lower quantum efficacy of SiQD 1050 which renders them 
more difficult for observation by means of fluorescence microscopy or by so called 
―blue-shift‖ of emission spectra due to degradation of SiQD 1050 inside the cells 
which was also described in the work of Jin et al.  (Jin et al., 2018). 
Additionally, SiQD 1100 were employed for detailed study of their uptake and 
trafficking inside the SAOS-2 cells due to their more stable behavior in cell culture. 
This research is summarized in PART III of the thesis (unpublished data E and F). 
Real-time tracking of nanoparticles in cell culture is not usually performed in the 
studies, since most of the experiments are conducted on cells fixed at selected time 
points. Anyway, imaging of live cells in time enables visualization of nanoparticle 
trajectories inside the cells (Ferrati et al., 2010) or accompanied with vital staining 
enables observation of nanoparticle internalization through the membrane into inner 
cell compartments (Pang et al., 2016). In our case, we were interested in fundamental 
information about the approximate time-point of SiQD 1100 uptake by SAOS-2 cells 
and the subsequent fate of their signal inside the cells as these experiments preceded 
all following visualization studies with SiQD 1100.  In order to obtain the correct 
sufficient signal of SiQD 1100, the high mercury lamp intensity of 330 – 380 nm 
(UV) was used for excitation for prolonged (10 seconds) exposition time. In most of 
the cells, SiQD 1100 signal was detected already after 30 minutes upon addition 
which is in agreement with the research of Ohta et al. where the same concentration 
of different type of SiQDs was observed inside the endothelial cells (Ohta et al., 
2012). The mentioned publication further describes the gradual accumulation of 
SiQDs inside the cells until reaching the plateau value around 200 minutes. 
Unfortunately, this result of our real-time live imaging could not be estimated due to 
mentioned immense UV irradiation which led to cell death over first 180 minutes. 
Consequently, we stated that SiQD 1100 are not suitable for live-imaging as long as 
mentioned short wavelengths are necessary for their excitation. Moreover, for 
biological applications not only harmful effect but also the limited tissue penetration 
of UV light should be taken into account (Shi et al., 2018).  
Next time-lapse imaging followed on the results of publication C. This time, 
the aim was to assess whether SiQD 1100 are internalized into the SAOS-2 cell by 
endocytosis and if so, then at which time-point they are present in late endosomes or 
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lysosomes. Since the formation of PC apparently influenced the accumulation of 
SiQD 1100 in vesicular structures inside the cells, this study was performed only in 
the presence of FBS in cultivation medium. Interpretation of colocalization by 
Manders split coefficient in our case was more clear and relevant than traditionally 
used Pearson‘s correlation coefficient (Ji et al., 2018; Pang et al., 2016). The 
outcome of colocalization assessment revealed the initial (1 hour) high spatial 
correlation of SiQD 1100 with late endosomes which further decreased in time. This 
trend was estimated both for Manders and Pearson‘s coefficient as well as for 2D and 
3D projections. The colocalization of SiQD 1100 with lysosomes showed in all cases 
the lowest values at 4 hour time-points while the highest portion of colocalization 
was mostly estimated at 24 hours. The indistinct time-lapse influence cannot imply 
whether SiQD 1100 are finally trafficked and accumulated in lysosomes as this 
finding was approved by lot of researchers (Damalakiene et al., 2013; Ji et al., 2018; 
Wang et al., 2018; Zhang and Monteiro-Riviere, 2009). On the other hand, Pang et 
al. similarly observed significant colocalization of silicon nanoparticles with late 
endosomes at 4 hours with further decreasing trend until 8 hours. Since no 
colocalization was determined for lysozomes, authors suggest that nanoparticles 
escaped from late endosome into cell cytoplasm (Pang et al., 2016).  
Subsequently in the study of PART II of the thesis, we estimated the influence 
of PC formation on cytotoxic potential of SiQD 1100 in hMSCs, macrophages and 
monocytes THP-1. As SAOS-2 cells represent osteosarcoma cell line, certain 
differences in nanoparticle uptake were expected as it was reported in literature 
(Lunov et al., 2011; Osaka et al., 2009). And indeed, primary hMSCs exhibited 
noticeable resistance to SiQD 1100 impact both in the presence and absence of FBS. 
Also LDH detection showed higher incidence of necrosis in SAOS-2 than in hMSCs. 
This statement is consistent with the research of Faedmaleki et al. with silver 
nanoparticles which revealed their anticancer  potential due to significant higher 
inhibitory effect on malignant HepG2 cell line than on primary hepatocytes 
(Faedmaleki et al., 2014). Both forms of THP-1 cell line showed initial stimulation 
of metabolic activity in the presence of FBS which may be connected with the early 
inflammatory response facilitated by protein corona. Actually, the lack of FBS 




Next in PART II of the thesis, silicon-carbide nanoparticles were employed to 
the same test of cytotoxicity in the perspective of protein corona formation. This type 
of nanoparticle resembles the SiQD with long-time stability in aqueous solutions and 
high photoluminescence (Botsoa et al., 2008). The anticipated biocompatibility of 
SiCs arose from the research of chemically inert bulk SiC material (Yakimova et al., 
2007), yet as we know, the nanostructuring may reveal unforeseen characteristics. 
Previously, SiCs were already tested by other colleagues by AlamarBlue Cell 
Viability Assay Kit on human cervical adenocarcinoma cells (HeLa)  to determine 
half maximal inhibitory concentration (IC50 =  227,5 µg ml
-1
) (Beke et al., 2013). We 
observed negative effect of SiCs on SAOS-2 cells in the presence of FBS only at the 
highest concentration (250 µg ml
-1
), but unlike SiQDs, the metabolic activity still 
increased in time. The time-dependent increase of metabolic activity was also 
observed in the absence of FBS, yet all the tested concentration were stated as 
cytotoxic after 48h. These results indicate that SiCs rather inhibit the SAOS-2 cells, 
yet in the absence of proteins from FBS the inhibition causes more significant 
damage. Thus for standard conditions we came to similar conclusion as Beke et al. 
but it should be emphasized that both tests were performed with carcinoma cell lines 
(Beke et al., 2013). Moreover to the comparison of both studies, in the case of Beke 
et al. the direct injection of SiCs into hippocampal CA1 pyramidal cells was 
employed in order to visualize them by two-photon excitation which showed a 
significant response. In our case, though, only cell-mediated uptake was visualized, 
yet no specific SiCs signal was observed even after two-photon excitation. We 
attribute this distinction to the disproportionate amount of SiCs inside the cells after 
direct injection and after passive cell uptake. Accordingly, insufficient amount of 
SiCs in cells could not be detected due to immense autofluorescence of the cells in 
the emission range of SiCs.  
Nanoparticles of metal origin were used for cytotoxicity evaluation in PART 
IV of the thesis (publication G). Platinum and especially gold nanoparticles have 
been tested for various biomedical applications for decades (antibacterial, antiviral, 
anticancer treatment, nano-enzyme activity), yet still new difficulties in their 
preparation emerge as the new findings in the field of cytotoxicity are continuously 
discovered (Soenen et al., 2015). Specific harmful effect of both AuNPs and PtNPs is 
still not fully understood, but currently, significant influence on metal nanoparticles 
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cytotoxicity is attributed to the contaminants from synthesis processes (endotoxins, 
organic solvents, toxic reagents) (Pedone et al., 2017). Due to this knowledge, 
mainly the physical or so called ―green‖ synthesis (Siegel et al., 2013) of metal 
nanoparticles is nowadays preferred for prospective applications in biology and 
biomedicine. AuNPs and PtNPs in our study were prepared by physical method of 
direct sputtering into liquid polyethylene glycol which represents simple and 
environmentally friendly synthesis with reproducible results. Since the cytotoxicity 
tests were performed for the first time with these types of Au and PtNPs, study of 
their behavior in cultivation media was employed prior to the actual evaluation with 
SAOS-2 cells. The initial divergent characteristics of size, shape and zeta potential 
between AuNPs and PtNPs dramatically changed after their addition into cell 
cultivation medium resulting in equalization of the mentioned parameters. Similar 
situation was described by Tlotleng et al. in their study of gold nanoparticles with 
different surface functionalization which original different characteristics equalized 
in the contact with proteins and salts from cultivation medium (Tlotleng et al., 2016). 
Surprisingly, despite their final comparable characteristics and concentrations used, 
more cytotoxic effect was evaluated for AuNPs after 24 hours cultivation. It is 
apparent, that the origin of the cytotoxicity still lies in the fundamental differences of 
these two metals which may cause variable reactivity or catalytic activity in 
biological environment. The importance of the thorough cytotoxicity assessment of 
specific nanoparticles should be highlighted as it is demonstrated by comparison of 
our results with the work of Hashimoto et al., where oppositely platinum 
nanoparticles demonstrated more cytotoxic effect than golden nanoparticles 
(Hashimoto et al., 2016). 
In conclusion to this nanoparticle section, our studies provided important 
information about the crucial influence of even slight differences in nanoparticle 
characteristics which can lead to extensively dissimilar behavior in the cell culture 
environment. We tested three different types of fluorescent silicon-based 
nanoparticles (SiQD 1100, SiQD 1050 and SiCs) and two types of metal 
nanoparticles (AuNPs and PtNPs) and despite their resembling structure (silicon-
based nanoparticles) and size, significantly different interactions were observed with 
standard SAOS-2 cell line. Principally, the influence of proteins from FBS forming 
PC caused immense differences between the behavior of even chemically identical 
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SiQD 1100 and SiQD 1050. We addressed this discrepancy to the possibly different 
structure of PC caused by differing surface chemistry (zeta potential). Taken 
together, generalization of nanoparticle cytotoxicity based simply on the material 
characteristics should always be avoided. Moreover, it is emphatically advised to 
perform initial in vitro experiments from the perspective of future biomedical 






I. The evaluation of biological responses of four different cell types to six 
samples of ultra-fine grain titanium (three types of grain sizes with two 
types of surface treatment) consisted of proliferation, metabolic activity 
and cell area assessment accompanied with cell morphology description.  
Osteoblasts (SAOS-2 cell line) demonstrated positive feedback on all 
UFG-Ti samples in mentioned criteria for cytocompatibility. Different 
distribution of focal adhesion plaques of SAOS-2 cells on samples with 
diverse surface treatment correlated with their topography features. 
Collagen type I production by SAOS-2 cells showed increase on all 
UFG-Ti samples compared to polystyrene (PS) control.  
Primary cells represented by hMSCs and NHDF evinced distinct 
sensitivity to the UFG-Ti samples which was manifested by successive 
adaptation to the surface.  
For keratinocytes (HaCaT cell line), UFG-Ti was not considered as a 
suitable material for their prosper growth. Low immunogenicity of UFG-
Ti was approved by inflammatory cytokines detection in blood samples.  
All UFG-Ti samples were confirmed as stimulating surfaces for the 
growth of osteoblasts and thus this material was recommended for future 
bone or dental implant development. 
 
II. Description of elemental reactions of cells to fluorescent silicon co-doped 
quantum dots SiQD 1100 (4 nm), SiQD 1050 (3 nm) and fluorescent 
silicon carbide nanoparticles SiCs (2 nm) elucidated crucial role of 
protein corona on nanoparticle final cytotoxicity. 
Although SiQD 1050 exhibited low cytotoxic effect towards SAOS-2 
cells, visual inspection revealed their huge aggregation with proteins in 
cultivation medium which hindered their uptake by cells. Nevertheless, 
such effect would have fatal consequences upon application into living 
organism. Significant cytotoxic effect of SiQD 1050 was observed in 
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protein corona absence, yet it was not possible to detect them inside the 
cells due to possible photoluminescence shift.  
Cytotoxic concentrations of SiQD 1100 were estimated for SAOS-2 
cells, hMSCs and monocytic cell line THP-1 (monocytes, macrophages) 
in the presence and absence of protein corona. Primary hMSCs 
demonstrated higher resistance to SiQD 1100 than the cell lines. Both 
forms of THP-1 cells were stimulated by SiQD 1100 with protein corona 
during first six hours.  
Microscopic visualization of SiQD 1100 in SAOS-2 cells confirmed their 
presence inside the cells both with and without protein corona although 
the pathways of uptake probably differ. 
Cytotoxic concentrations were also estimated for SiCs in culture of 
SAOS-2 cells in the presence and absence of protein corona. Following 
detailed studies were further performed by my colleagues. 
The results provided information about the in vitro cytotoxicity of 
silicon-based nanoparticles and clarified the relation of cytotoxic effect 
with the complex interactions of nanoparticles and biological 
environment. 
 
III. Optimization of protocols for microscopic imaging of fluorescent 
silicon nanoparticles were performed with SiQD 1100 as they place high 
demands on visualization in biological environment. Specific 
characteristics of silicon photoluminescence were implemented into 
technical adjustment of wide-field and confocal microscopes. Resulting 
protocols enabled visualization of silicon nanoparticles with low quantum 
efficacies even in near-infra red ranges of visible spectra. Additionally, 
proposed standardized experimental set-up facilitated separation of the 
positive silicon nanoparticle signal from the cell autofluorescence, yet 
further optimizations have to be employed as this protocol did not fit to 
silicon carbide nanoparticles with emission peak (450 nm) in biological 
autofluorescence highest emission range.  
Advanced imaging techniques enabled 3D spatial visualization of SiQD 
1100 inside the SAOS-2 cells and colocalization of their signal with late 
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endosomes and lysosomes which suggested possible time-dependent 
internalization of SiQD 1100 with protein corona inside late endosomes. 
Another technique of real-time live imaging was not recommended for 
visualization of SiQD 1100 due to excessive cell death after UV 
irradiation. 
Established protocols for different microscopes will continue to facilitate 
the imaging of any new type of silicon-based nanoparticles in cell 
cultures. 
 
IV. Determination of SAOS-2 cells viability in the presence of the gold and 
platinum nanoparticles was performed according to the well-established 
protocols for cytotoxicity testing of silicon-based nanoparticles. Despite 
similar characteristics of both nanoparticles in cell cultivation medium, 
AuNPs were confirmed as more cytotoxic than PtNPs. Evaluation were 
conducted only under standard cultivation conditions at single time-point 
(24 hours). Further detailed evaluations were already performed by my 
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